| For: | Miura K, Ohnishi H. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(23): 7381-7391 [PMID: 24966608 DOI: 10.3748/wjg.v20.i23.7381] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i23/7381.htm |
| Number | Citing Articles |
| 1 |
Praveen Kumar Conjeevaram Selvakumar, Mohammad Nasser Kabbany, Naim Alkhouri. Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter. Pediatric Drugs 2018; 20(4) doi: 10.1007/s40272-018-0292-2
|
| 2 |
Sok-Ja Janket, Martha E. Nunn, Erdjan Salih, Alison E. Baird. Translational Oral Health Research. 2018; doi: 10.1007/978-3-319-78205-8_8
|
| 3 |
Cuijiao Feng, Qiuwen He, Lai-Yu Kwok, Zhihong Sun. Gut microbiota-derived metabolites as systemic messengers: mechanisms of gut-organ communication and translational opportunities. Trends in Food Science & Technology 2026; 174 doi: 10.1016/j.tifs.2026.105818
|
| 4 |
Qinge Ma, Kejia Liu, Chenyu Chang, Lei Wang, Zhangyang Shen, Jiaxin Li, Mozili Adu, Qingyuan Lin, Huilian Huang, Xutao Wu, Rongrui Wei. Metabolic dysfunction‑associated steatotic liver disease: Pathogenesis, model and treatment (Review). International Journal of Molecular Medicine 2025; 56(6) doi: 10.3892/ijmm.2025.5668
|
| 5 |
Sanjeev R. Phatak, Banshi Saboo, Shivangi Dwivedi, Padmanabh Zinzuwadia, Dharmendra Panchal, Abhilasha Ganguli, Dhruvi Hasnani. Sweetening Sixteen. Journal of Diabetology 2021; 12(1) doi: 10.4103/jod.jod_9_20
|
| 6 |
Laura López-Gómez, Alexandra Alcorta, Raquel Abalo. Probiotics and Probiotic-like Agents against Chemotherapy-Induced Intestinal Mucositis: A Narrative Review. Journal of Personalized Medicine 2023; 13(10) doi: 10.3390/jpm13101487
|
| 7 |
Stavros Bashiardes, Hagit Shapiro, Shachar Rozin, Oren Shibolet, Eran Elinav. Non-alcoholic fatty liver and the gut microbiota. Molecular Metabolism 2016; 5(9) doi: 10.1016/j.molmet.2016.06.003
|
| 8 |
Isabella Reccia, Jayant Kumar, Cherif Akladios, Francesco Virdis, Madhava Pai, Nagy Habib, Duncan Spalding. Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism 2017; 72 doi: 10.1016/j.metabol.2017.04.011
|
| 9 |
Salvatore Pezzino, Maria Sofia, Gloria Faletra, Chiara Mazzone, Giorgia Litrico, Gaetano La Greca, Saverio Latteri. Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome. Biology 2022; 11(11) doi: 10.3390/biology11111622
|
| 10 |
Muhammad Y. Khan, Albana B. Mihali, Muhammad S. Rawala, Aysha Aslam, Waqas J. Siddiqui. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease – a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2019; 31(6) doi: 10.1097/MEG.0000000000001371
|
| 11 |
A. V. Bogolyubova, E. E. Mishina, P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, A. Yu. Mayorov, P. V. Belousov. EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS. Medical Immunology (Russia) 2019; 21(5) doi: 10.15789/1563-0625-2019-5-945-952
|
| 12 |
. 2020; doi: 10.70675/f14945bez0129z4664z9e05zf89d7c00e4a7
|
| 13 |
Kylynda C. Bauer, Paula T. Littlejohn, Victoria Ayala, Anna Creus-Cuadros, B. Brett Finlay. Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective. Gastroenterology 2022; 162(7) doi: 10.1053/j.gastro.2022.01.058
|
| 14 |
David Porras, Esther Nistal, Susana Martínez-Flórez, Sandra Pisonero-Vaquero, José Luis Olcoz, Ramiro Jover, Javier González-Gallego, María Victoria García-Mediavilla, Sonia Sánchez-Campos. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radical Biology and Medicine 2017; 102 doi: 10.1016/j.freeradbiomed.2016.11.037
|
| 15 |
Kouichi Miura, Mitsuaki Ishioka, Katsunori Iijima. The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease. Journal of Obesity & Metabolic Syndrome 2017; 26(2) doi: 10.7570/jomes.2017.26.2.86
|
| 16 |
Ridda Manzoor, Weshah Ahmed, Nariman Afify, Mashal Memon, Maryam Yasin, Hamda Memon, Mohammad Rustom, Mohannad Al Akeel, Noora Alhajri. Trust Your Gut: The Association of Gut Microbiota and Liver Disease. Microorganisms 2022; 10(5) doi: 10.3390/microorganisms10051045
|
| 17 |
Seema Sharma, Nishant Tiwari, Sampat Singh Tanwar. The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(9) doi: 10.1007/s00210-025-04069-z
|
| 18 |
Breann E Abernathy, Tonya C Schoenfuss, Allison S Bailey, Daniel D Gallaher. Polylactose Exhibits Prebiotic Activity and Reduces Adiposity and Nonalcoholic Fatty Liver Disease in Rats Fed a High-Fat Diet. The Journal of Nutrition 2021; 151(2) doi: 10.1093/jn/nxaa376
|
| 19 |
Audrey Neyrinck, Bernard Taminiau, Hannah Walgrave, Georges Daube, Patrice Cani, Laure Bindels, Nathalie Delzenne. Spirulina Protects against Hepatic Inflammation in Aging: An Effect Related to the Modulation of the Gut Microbiota?. Nutrients 2017; 9(6) doi: 10.3390/nu9060633
|
| 20 |
Aslı Yiğit, Gülhan Samur. Mechanisms behind the Role of SIBO in Non-Alcoholic Fatty Liver
Disease: An Interplay between Liver, Gut Microbiota and Nutrition. Current Nutrition & Food Science 2023; 19(2) doi: 10.2174/1573401318666220520100202
|
| 21 |
Mitsuaki Ishioka, Kouichi Miura, Shinichiro Minami, Yoichiro Shimura, Hirohide Ohnishi. Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models. Digestive Diseases and Sciences 2017; 62(2) doi: 10.1007/s10620-016-4393-x
|
| 22 |
Jun-Ling Han, Hui-Ling Lin. Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective. World Journal of Gastroenterology 2014; 20(47): 17737-17745 doi: 10.3748/wjg.v20.i47.17737
|
| 23 |
Ya. M. Vakhrushev, E. V. Suchkova, A. P. Lukashevich. Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2020; 92(2) doi: 10.26442/00403660.2020.02.000400
|
| 24 |
Ying Geng, Yifang Li, Ge Liu, Jian Jiao. Identification of biomarkers for the diagnosis in colorectal polyps and metabolic dysfunction-associated steatohepatitis (MASH) by bioinformatics analysis and machine learning. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-81120-8
|
| 25 |
Joanna K. Hodges, Geoffrey Y. Sasaki, Richard S. Bruno. Anti-inflammatory activities of green tea catechins along the gut–liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies. The Journal of Nutritional Biochemistry 2020; 85 doi: 10.1016/j.jnutbio.2020.108478
|
| 26 |
Xueyuan Fu, Changwei Wang, Zhaoxia Yang, Junhong Yu, Jianfeng Wang, Wanxiu Cao, Chuyi Liu, Hua Yin, Bafang Li, Xiaomei Feng, Fen Du, Hu Hou. Moderate Beer Consumption Ameliorated Aging‐Related Metabolic Disorders Induced by D‐Galactose in Mice via Modulating Gut Microbiota Dysbiosis. Food Science & Nutrition 2025; 13(8) doi: 10.1002/fsn3.70678
|
| 27 |
Paula Andréa Malveira Cavalcante, Marcos Fernandes Gregnani, Jessica Salles Henrique, Fábio Henrique Ornellas, Ronaldo Carvalho Araújo. Aerobic but not Resistance Exercise Can Induce Inflammatory Pathways via Toll-Like 2 and 4: a Systematic Review. Sports Medicine - Open 2017; 3(1) doi: 10.1186/s40798-017-0111-2
|
| 28 |
|
| 29 |
Dan Feng, Hongmin Zhang, Xin Jiang, Jun Zou, Qingrong Li, Haiyan Mai, Dongfang Su, Wenhua Ling, Xiang Feng. Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 mice. Environmental Pollution 2020; 265 doi: 10.1016/j.envpol.2020.114880
|
| 30 |
Zhenxiong Zhang, Peiheng He, Li Yang, Jun Gong, Renyi Qin, Min Wang. Posttranslational modifications of YAP/TAZ: molecular mechanisms and therapeutic opportunities. Cellular & Molecular Biology Letters 2025; 30(1) doi: 10.1186/s11658-025-00760-4
|
| 31 |
Xingyao Pei, Shusheng Tang, Haiyang Jiang, Wenjuan Zhang, Gang Xu, Zonghui Zuo, Zhenhui Ren, Chun Chen, Yao Shen, Cun Li, Daowen Li. Paeoniflorin recued hepatotoxicity under zinc oxide nanoparticles exposure via regulation on gut-liver axis and reversal of pyroptosis. Science of The Total Environment 2023; 904 doi: 10.1016/j.scitotenv.2023.166885
|
| 32 |
Role of prokineticins and T-reg cells in obesity-associated metabolic oxidative dysregulation in NAFLD. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-97969-2
|
| 33 |
Kangxiao Guo, Sisheng Xu, Zhaofeng Zeng. “Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1050709
|
| 34 |
. 2015; doi: 10.70675/9abf7475z9c9cz4f2dz86dbzc17960d72d65
|
| 35 |
Diptadip Dattaroy, Ratanesh Kumar Seth, Suvarthi Das, Firas Alhasson, Varun Chandrashekaran, Gregory Michelotti, Daping Fan, Mitzi Nagarkatti, Prakash Nagarkatti, Anna Mae Diehl, Saurabh Chatterjee. Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 310(7) doi: 10.1152/ajpgi.00259.2015
|
| 36 |
Daphne van der Heide, Ralf Weiskirchen, Ruchi Bansal. Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02852
|
| 37 |
Xuhui Wu, Dahai Yu, Yunkun Ma, Xuexun Fang, Pengda Sun. Function and therapeutic potential of Amuc_1100, an outer membrane protein of Akkermansia muciniphila: A review. International Journal of Biological Macromolecules 2025; 308 doi: 10.1016/j.ijbiomac.2025.142442
|
| 38 |
Mustafa Karabicici, Yagmur Azbazdar, Evin Iscan, Gunes Ozhan. Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic Diseases. Membranes 2021; 11(11) doi: 10.3390/membranes11110844
|
| 39 |
Ting Qiu, Xiaodong Zhu, Jingju Wu, Wenyuan Hong, Weitao Hu, Taiyong Fang. Mechanisms of rifaximin inhibition of hepatic fibrosis in mice with metabolic dysfunction associated steatohepatitis through the TLR4/NFκB pathway. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-92282-4
|
| 40 |
Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, Niki Katsiki, Dimitri P. Mikhailidis, Peter P. Toth, Ioanna Gouni-Berthold, John Mancini, David Marais, Patrick Moriarty, Massimiliano Ruscica, Amirhossein Sahebkar, Dragos Vinereanu, Arrigo Francesco Giuseppe Cicero, Maciej Banach, Julio Acosta, Mutaz Al-Khnifsawi, Fahad Alnouri, Fahma Amar, Atanas G. Atanasov, Gani Bajraktari, Maciej Banach, Ioanna Gouni-Berthold, Sonu Bhaskar, Agata Bielecka-Dąbrowa, Bojko Bjelakovic, Eric Bruckert, Ibadete Bytyçi, Alberto Cafferata, Richard Ceska, Arrigo F.G. Cicero, Krzysztof Chlebus, Xavier Collet, Magdalena Daccord, Olivier Descamps, Dragan Djuric, Ronen Durst, Marat V. Ezhov, Zlatko Fras, Dan Gaita, Ioanna Gouni-Berthold, Adrian V. Hernandez, Steven R. Jones, Jacek Jozwiak, Nona Kakauridze, Amani Kallel, Niki Katsiki, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martinez, Mohsen Mazidi, Dimitri P. Mikhailidis, Erkin Mirrakhimov, Andre R. Miserez, Olena Mitchenko, Natalya P. Mitkovskaya, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Peter E. Penson, Zaneta Petrulioniene, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Dina Radenkovic, Michał Rakowski, Jemaa Riadh, Dimitri Richter, Manfredi Rizzo, Massimiliano Ruscica, Amirhossein Sahebkar, Maria-Corina Serban, Abdullah M.A Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Peter P. Toth, Margus Viigimaa, Pedro Valdivielso, Dragos Vinereanu, Branislav Vohnout, Stephan von Haehling, Michal Vrablik, Nathan D. Wong, Hung-I Yeh, Jiang Zhisheng, Andreas Zirlik. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP). Pharmacological Research 2023; 189 doi: 10.1016/j.phrs.2023.106679
|
| 41 |
Marija Branković, Igor Jovanović, Marija Dukić, Tijana Radonjić, Svetlana Oprić, Slobodan Klašnja, Marija Zdravković. Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences 2022; 23(9) doi: 10.3390/ijms23095146
|
| 42 |
Mária Nováková, Veronika Vyletelová, Barbora Hlubinová, Hana Kiňová Sepová, Ľudmila Pašková. Impact of culture medium on the interpretation of qRT-PCR data in HepG2 incubated with lactobacilli. Letters in Applied Microbiology 2024; 77(6) doi: 10.1093/lambio/ovae050
|
| 43 |
Shendong Wang, Junhao Yin, Zhaojun Liu, Xin Liu, Ge Tian, Xijian Xin, Yiming Qin, Xiujing Feng. Metabolic disorders, inter-organ crosstalk, and inflammation in the progression of metabolic dysfunction-associated steatotic liver disease. Life Sciences 2024; 359 doi: 10.1016/j.lfs.2024.123211
|
| 44 |
Alejandra Altamirano-Barrera, Misael Uribe, Norberto C. Chávez-Tapia, Natalia Nuño-Lámbarri. The role of the gut microbiota in the pathology and prevention of liver disease. The Journal of Nutritional Biochemistry 2018; 60 doi: 10.1016/j.jnutbio.2018.03.006
|
| 45 |
Eva Juárez-Hernández, Montserrat Berrospe-Alfaro, Misael Uribe, Iván López-Mendez. Metabolic Impact of Alcohol Consumption in MASLD: Understanding MetALD and Beyond. Journal of Clinical and Experimental Hepatology 2025; 15(6) doi: 10.1016/j.jceh.2025.103114
|
| 46 |
Yujing Fan, Yunpeng Li, Yanjie Chu, Jing Liu, Lin Cui, Dekai Zhang. Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.608498
|
| 47 |
Wei-Lin Wang, Shao-Yan Xu, Zhi-Gang Ren, Liang Tao, Jian-Wen Jiang, Shu-Sen Zheng. Application of metagenomics in the human gut microbiome. World Journal of Gastroenterology 2015; 21(3): 803-814 doi: 10.3748/wjg.v21.i3.803
|
| 48 |
Ebrahim Abbasi Oshaghi. Role of Toll-like Receptor 4 in the Development of Non-alcoholic Fatty Liver Disease. Avicenna Journal of Medical Biochemistry 2018; 6(2) doi: 10.15171/ajmb.2018.06
|
| 49 |
Rosa Lombardi, Giuseppina Pisano, Silvia Fargion, Anna Ludovica Fracanzani. Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Exploration of Medicine 2021; doi: 10.37349/emed.2021.00030
|
| 50 |
Brandon J. Perumpail, Andrew A. Li, Nimy John, Sandy Sallam, Neha D. Shah, Waiyee Kwong, George Cholankeril, Donghee Kim, Aijaz Ahmed. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD. Diseases 2019; 7(1) doi: 10.3390/diseases7010027
|
| 51 |
Mingnuan Han, Ting Zhang, Wen Gu, Xingxin Yang, Ronghua Zhao, Jie Yu. 2,3,5,4'‑tetrahydroxy‑stilbene‑2‑O‑β‑D‑glucoside attenuates methionine and choline‑deficient diet‑induced non‑alcoholic fatty liver disease. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6300
|
| 52 |
Seyyed Mohammad Reza Hashemnia, Reza Meshkani, Fahimeh Zamani-Garmsiri, Maryam Shabani, Maryam Tajabadi-Ebrahimi, Iraj Ragerdi Kashani, Seyed Davar Siadat, Samaneh Mohassel Azadi, Solaleh Emamgholipour. Amelioration of obesity-induced white adipose tissue inflammation by Bacillus coagulans T4 in a high-fat diet-induced obese murine model. Life Sciences 2023; 314 doi: 10.1016/j.lfs.2022.121286
|
| 53 |
Libin Chen, Xintong Jin, Jian Ma, Bo Xiang, Xiayu Li. YAP at the progression of inflammation. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1204033
|
| 54 |
Yuan Gao, Tian Tian. mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy. International Journal of Molecular Sciences 2023; 24(14) doi: 10.3390/ijms241411811
|
| 55 |
Kelli A. Lytle, Carmen P. Wong, Donald B. Jump, Anna Alisi. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice. PLOS ONE 2017; 12(4) doi: 10.1371/journal.pone.0173376
|
| 56 |
Xiangsheng Cai, Jincheng Dai, Yingjun Xie, Shu Xu, Minqi Liu. Multi-omics study unravels gut microbiota and metabolites alteration in patients with Wilson's disease. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-71740-5
|
| 57 |
Wenyu Zhao, Min Guo, Jun Feng, Zhennan Gu, Jianxin Zhao, Hao Zhang, Gang Wang, Wei Chen. Myristica fragrans Extract Regulates Gut Microbes and Metabolites to Attenuate Hepatic Inflammation and Lipid Metabolism Disorders via the AhR–FAS and NF-κB Signaling Pathways in Mice with Non-Alcoholic Fatty Liver Disease. Nutrients 2022; 14(9) doi: 10.3390/nu14091699
|
| 58 |
Rongxue Wei, Chunchun Han, Shouhai Wei, Yongqiang Teng, Liang Li, Hehe Liu, Shengqiang Hu, Bo Kang, Hengyong Xu. Integrative analysis of transcriptome and lipidome reveals fructose pro-steatosis mechanism in goose fatty liver. Frontiers in Nutrition 2023; 9 doi: 10.3389/fnut.2022.1052600
|
| 59 |
H. Ünsal, G. Doğan, E. Koç Yıldırım, G. Başbülbül, C. Ünsal, L. Karagenç. Comparison of Gut Microbiota and Toll-Like Receptor 2 and 4 (TLR2/4) Gene Expression in Young Adult Mice Conceived by Natural Pregnancy or Assisted Reproductive Technologies (ART). Biology Bulletin 2026; 53(1) doi: 10.1134/S1062359025611887
|
| 60 |
Benedetta Campana, David Semela, Markus Heim, Christine Bernsmeier. Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?. EMJ Hepatology 2015; doi: 10.33590/emjhepatol/10314903
|
| 61 |
Bharati Kadamb Patel, Kadamb Haribhai Patel, Shabbir M. Moochhala. Gut microbiota intervention strategies using active components from medicinal herbs to evaluate clinical efficacy of type 2 diabetes – A review. Clinical and Translational Discovery 2023; 3(1) doi: 10.1002/ctd2.170
|
| 62 |
Josip Stojic, Michał Kukla, Ivica Grgurevic. The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status. Diagnostics 2023; 13(18) doi: 10.3390/diagnostics13182960
|
| 63 |
Minghui Zhu, Omer M. A. Dagah, Billton Bryson Silaa, Jun Lu. Thioredoxin/Glutaredoxin Systems and Gut Microbiota in NAFLD: Interplay, Mechanism, and Therapeutical Potential. Antioxidants 2023; 12(9) doi: 10.3390/antiox12091680
|
| 64 |
Ting Bao, Fang He, Xiaoxia Zhang, Lili Zhu, Zhen Wang, Haixia Lu, Ting Wang, Yiwei Li, Shaoqi Yang, Hao Wang. Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-Mψ-Nuclear Factor-κB-Nod-Like Receptor Protein 3 Pathway via gut-Liver Axis in Mice. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.558525
|
| 65 |
Hailong Li, Ziyang Xie, Yao Zhang, Yue Liu, Aijing Niu, Yingying Liu, Linbo Zhang, Lili Guan. Rosa rugosa polysaccharide attenuates alcoholic liver disease in mice through the gut-liver axis. Food Bioscience 2021; 44 doi: 10.1016/j.fbio.2021.101385
|
| 66 |
Alimire Abulikemu, Xinying Zhao, Hailin Xu, Yan Li, Ru Ma, Qing Yao, Ji Wang, Zhiwei Sun, Yanbo Li, Caixia Guo. Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress. Redox Biology 2023; 59 doi: 10.1016/j.redox.2022.102569
|
| 67 |
Chang Yang, Bo Liu, Liangkun Pan, Dong Xia, Cunxin Sun, Xiaochuan Zheng, Peng Chen, He Hu, Qunlan Zhou. Impact of Soybean Bioactive Peptides on Growth, Lipid Metabolism, Antioxidant Ability, Molecular Responses, and Gut Microbiota of Oriental River Prawn (Macrobrachium nipponense) Fed with a Low-Fishmeal Diet. Biology 2024; 14(1) doi: 10.3390/biology14010011
|
| 68 |
Garima Maheshwari, Gaiping Wen, Denise K. Gessner, Robert Ringseis, Günter Lochnit, Klaus Eder, Holger Zorn, Thomas Timm. Tandem mass tag-based proteomics for studying the effects of a biotechnologically produced oyster mushroom against hepatic steatosis in obese Zucker rats. Journal of Proteomics 2021; 242 doi: 10.1016/j.jprot.2021.104255
|
| 69 |
Lu-Jie Liu, Yu-Rong Kang, Yan-Feng Xiao. Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity. World Journal of Pediatrics 2021; 17(4) doi: 10.1007/s12519-021-00444-x
|
| 70 |
Jing Xiao, Huanyu Xiang, Hongyan Xiang, Zilin Sun, Jing Xu, Hong Ren, Peng Hu, Mingli Peng. GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota. European Journal of Pharmacology 2023; 960 doi: 10.1016/j.ejphar.2023.176113
|
| 71 |
Jarren R. Oates, Melanie C. McKell, Maria E. Moreno-Fernandez, Michelle S. M. A. Damen, George S. Deepe, Joseph E. Qualls, Senad Divanovic. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02893
|
| 72 |
Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future. Probiotics and Antimicrobial Proteins 2025; 17(2) doi: 10.1007/s12602-024-10365-6
|
| 73 |
Fan Xiong, Shangong Wu, Lu Qin, Mijuan Shi, Wenxiang Li, Hong Zou, Ming Li, Guitang Wang. Transcriptome analysis of grass carp provides insights into disease-related genes and novel regulation pattern of bile acid feedback in response to lithocholic acid. Aquaculture 2019; 500 doi: 10.1016/j.aquaculture.2018.10.015
|
| 74 |
Daiyang Xia, Lin Yang, Yu Li, Jianying Chen, Xiufen Zhang, Heng Wang, Shuangshuang Zhai, Xianzhi Jiang, Giuseppe Meca, Shunxiang Wang, Liang Huang, Shanshan Zhu, Yang Fu, Weiqing Ma, Yongwen Zhu, Hui Ye, Wence Wang. Melatonin alleviates Ochratoxin A-induced liver inflammation involved intestinal microbiota homeostasis and microbiota-independent manner. Journal of Hazardous Materials 2021; 413 doi: 10.1016/j.jhazmat.2021.125239
|
| 75 |
Yan Yun SHU, Li Lin HU, Jin YE, Ling YANG, Yu JIN. Rifaximin alleviates MCD diet-induced NASH in mice by restoring the gut microbiota and intestinal barrier. Life Sciences 2024; 357 doi: 10.1016/j.lfs.2024.123095
|
| 76 |
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, Alessandra Marrazzo, Luca Rinaldi, Luigi Elio Adinolfi. Nonalcoholic fatty liver disease: Evolving paradigms. World Journal of Gastroenterology 2017; 23(36): 6571-6592 doi: 10.3748/wjg.v23.i36.6571
|
| 77 |
Lu Huang, Wei Ding, Ming-Qiang Wang, Zheng-Gen Wang, Hong-Hui Chen, Wen Chen, Qiong Yang, Ting-Na Lu, Qing Yang, Ji-Man He. Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4. Journal of International Medical Research 2019; 47(10) doi: 10.1177/0300060519859750
|
| 78 |
雪 罗. Research Progress of Non-Alcoholic Fatty Liver Disease from the Perspective of Intestinal Flora. Advances in Clinical Medicine 2025; 15(03) doi: 10.12677/acm.2025.153639
|
| 79 |
Satdarshan P.S. Monga, Jaideep Behari. Molecular Pathology. 2018; doi: 10.1016/B978-0-12-802761-5.00020-1
|
| 80 |
Xiao Li, Yiting Wang, Maocheng Xiong, Chunfang Xie, Dianxing Yang. The therapeutic effect of curcumin in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of animal studies. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1714245
|
| 81 |
Cynthia Aparecida de Castro, Manoela Maciel dos Santos Dias, Karina Ana da Silva, Sandra Aparecida dos Reis, Lisiane Lopes da Conceição, Letícia De Nadai Marcon, Luis Fernando de Sousa Moraes, Maria do Carmo Gouveia Peluzio. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; doi: 10.1007/978-94-007-7742-2_1-1
|
| 82 |
Mengdi Guo, Chenhui Zhu, Rongzhan Fu, Xiaoxuan Ma, Zhiguang Duan, Daidi Fan. Ginsenoside Rk3 Regulates Nonalcoholic Steatohepatitis by Modulation of Intestinal Flora and the PI3K/AKT Signaling Pathway in C57BL/6 Mice. Journal of Agricultural and Food Chemistry 2023; 71(24) doi: 10.1021/acs.jafc.3c00789
|
| 83 |
MIN WANG, SHUIPING ZHAO, MINGYUE TAN. bZIP transmembrane transcription factor CREBH: Potential role in non-alcoholic fatty liver disease (Review). Molecular Medicine Reports 2016; 13(2) doi: 10.3892/mmr.2015.4749
|
| 84 |
Dong Wang, Ritsuko Yamase, Kyunghee Park, Hiromi Nishikawa, Andrew Shevchuk, Rebecca C. Coll, Yuri Korchev, Wei Wang, Yanjun Zhang. Real-Time Scanning
Ion Conductance Microscopy Reveals
MARCKS-Driven Morphological Remodeling and Nanomechanical Softening
during LPS-Induced Macrophage Polarization. Analytical Chemistry 2026; 98(32) doi: 10.1021/acs.analchem.6c01115
|
| 85 |
Gloria Komazin, Michael Maybin, Ronald W. Woodard, Thomas Scior, Dominik Schwudke, Ursula Schombel, Nicolas Gisch, Uwe Mamat, Timothy C. Meredith. Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal alkaline phosphatase. Journal of Biological Chemistry 2019; 294(50) doi: 10.1074/jbc.RA119.010836
|
| 86 |
Ting‐Chin David Shen, Nikolaos Pyrsopoulos, Vinod K. Rustgi. Microbiota and the liver. Liver Transplantation 2018; 24(4) doi: 10.1002/lt.25008
|
| 87 |
. 2019; doi: 10.70675/47517b92z4e00z41e1z828dzd86aa45af704
|
| 88 |
Ting Wang, Taichi Ishikawa, Minoru Sasaki, Toshimi Chiba. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.822190
|
| 89 |
Somaya Albhaisi, Arun J. Sanyal. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.665987
|
| 90 |
Ya. M. Vakhrushev, A. P. Lukashevich, E. V. Suchkova. Evaluation of enterohepatic circulation of the bile acids in patients with non-alcoholic fatty liver disease. Experimental and Clinical Gastroenterology 2023; (8) doi: 10.31146/1682-8658-ecg-216-8-73-78
|
| 91 |
Angelica Carreira dos Santos, Daniel Araki Ribeiro, Jessica Almeida da Cruz Ferreira, Odair Aguiar, Dan Linetzky Waitzberg, Claudia Cristina Alves. Inflammatory gene expression analysis after prebiotic, probiotic and synbiotic supplementation in experimental nonalcoholic fatty liver disease. Nutrition & Food Science 2019; 49(1) doi: 10.1108/NFS-04-2018-0119
|
| 92 |
Mu-Yeol Cho, Je-Hyun Eom, Eun-Mi Choi, Seung-Jo Yang, Dahye Lee, Young Youn Kim, Hye-Sung Kim, Inseong Hwang, Christopher Staley. Recent advances in therapeutic probiotics: insights from human trials. Clinical Microbiology Reviews 2025; 38(2) doi: 10.1128/cmr.00240-24
|
| 93 |
Dan Feng, Jun Zou, Dongfang Su, Haiyan Mai, Shanshan Zhang, Peiyang Li, Xiumei Zheng. Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation. Nutrition & Metabolism 2019; 16(1) doi: 10.1186/s12986-019-0410-3
|
| 94 |
Graciela Arguello, Elisa Balboa, Marco Arrese, Silvana Zanlungo. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015; 1852(9) doi: 10.1016/j.bbadis.2015.05.015
|
| 95 |
Xiang Zhang, Olabisi Oluwabukola Coker, Eagle SH Chu, Kaili Fu, Harry C H Lau, Yi-Xiang Wang, Anthony W H Chan, Hong Wei, Xiaoyong Yang, Joseph J Y Sung, Jun Yu. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut 2021; 70(4) doi: 10.1136/gutjnl-2019-319664
|
| 96 |
Wan-Ju Yeh, Jung Ko, Wen-Chih Huang, Wei-Yi Cheng, Hsin-Yi Yang. Crude extract of Camellia oleifera pomace ameliorates the progression of non-alcoholic fatty liver disease via decreasing fat accumulation, insulin resistance and inflammation. British Journal of Nutrition 2020; 123(5) doi: 10.1017/S0007114519003027
|
| 97 |
Jinliang Du, Rui Jia, Liping Cao, Zhengyan Gu, Qin He, Pao Xu, Guojun Yin, Yuzhong Ma. Regulatory effects of Glycyrrhiza total flavones on fatty liver injury induced by a high-fat diet in tilapia (Oreochromis niloticus) via the Nrf2 and TLR signaling pathways. Aquaculture International 2022; 30(3) doi: 10.1007/s10499-021-00787-2
|
| 98 |
Hiroshi Fukui. Gut Microbiota and Host Reaction in Liver Diseases. Microorganisms 2015; 3(4) doi: 10.3390/microorganisms3040759
|
| 99 |
Sana Raza, Archana Tewari, Sangam Rajak, Rohit A. Sinha. Vitamins and non-alcoholic fatty liver disease: A molecular insight. Liver Research 2021; 5(2) doi: 10.1016/j.livres.2021.03.004
|
| 100 |
Meng-yang Qu, Yan-fang Pan, Min Xie, K.H.M. Mansur, Y. Fu. Research progress of intestinal microecology in the occurrence and development of precancerous lesions of liver. E3S Web of Conferences 2021; 251 doi: 10.1051/e3sconf/202125102046
|
| 101 |
Weijun Cui, Xiangyang Zhu, Chunli Hu, Xueping Li, Xinling Song, Shiwei Yu, Dapeng Li, Chen Zhang. A review of food-derived polysaccharides in intervening in disorders of glucose and lipid metabolism: an inter-organ crosstalk between gut, liver, adipose tissue, and nervous system. Food Science and Human Wellness 2026; 15(2) doi: 10.26599/FSHW.2024.9250336
|
| 102 |
Peter Wilhelmsson. Integrative and Functional Medical Nutrition Therapy. 2020; doi: 10.1007/978-3-030-30730-1_35
|
| 103 |
Laia Bertran, Marta Portillo-Carrasquer, Salomé Martínez, Carmen Aguilar, Miguel Lopez-Dupla, David Riesco, Jessica Binetti, Margarita Vives, Fàtima Sabench, Daniel Del Castillo, Cristóbal Richart, Teresa Auguet. Expression of Jejunal Taste Receptors in Women with Morbid Obesity. Nutrients 2021; 13(7) doi: 10.3390/nu13072437
|
| 104 |
Thomas Greuter, Harmeet Malhi, Gregory J. Gores, Vijay H. Shah. Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. JCI Insight 2017; 2(17) doi: 10.1172/jci.insight.95354
|
| 105 |
Qi Li, Jiawei Gao, Jiashun Luo, Dihui Lin, Xinrui Wu. Mendelian randomization analyses support causal relationship between gut microbiota and childhood obesity. Frontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1229236
|
| 106 |
Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding. Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis. Clinical and Molecular Hepatology 2021; 27(2) doi: 10.3350/cmh.2020.0261
|
| 107 |
Amedeo Lonardo, Fabio Nascimbeni, Giovanni Targher, Mauro Bernardi, Ferruccio Bonino, Elisabetta Bugianesi, Alessandro Casini, Amalia Gastaldelli, Giulio Marchesini, Fabio Marra, Luca Miele, Filomena Morisco, Salvatore Petta, Fabio Piscaglia, Gianluca Svegliati-Baroni, Luca Valenti, Stefano Bellentani. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. Digestive and Liver Disease 2017; 49(5) doi: 10.1016/j.dld.2017.01.147
|
| 108 |
Michelle L Boland, Denise Oró, Kirstine S Tølbøl, Sebastian T Thrane, Jens Christian Nielsen, Taylor S Cohen, David E Tabor, Fiona Fernandes, Andrey Tovchigrechko, Sanne S Veidal, Paul Warrener, Bret R Sellman, Jacob Jelsing, Michael Feigh, Niels Vrang, James L Trevaskis, Henrik H Hansen. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source. World Journal of Gastroenterology 2019; 25(33): 4904-4920 doi: 10.3748/wjg.v25.i33.4904
|
| 109 |
Yu-Rim Chae, Hye-Bin Lee, Yu Ra Lee, Guijae Yoo, Eunjung Lee, Miri Park, Sang Yoon Choi, Ho-Young Park. Ameliorating effects of Orostachys japonica against high-fat diet-induced obesity and gut dysbiosis. Journal of Ethnopharmacology 2024; 333 doi: 10.1016/j.jep.2024.118443
|
| 110 |
Gianluca Svegliati-Baroni, Bárbara Patrício, Gessica Lioci, Maria Paula Macedo, Amalia Gastaldelli. Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH. International Journal of Molecular Sciences 2020; 21(16) doi: 10.3390/ijms21165820
|
| 111 |
Mikkel Breinholt Kjær, Jacob George, Konstantin Kazankov, Henning Grønbæk. Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?. Expert Review of Gastroenterology & Hepatology 2021; 15(1) doi: 10.1080/17474124.2020.1817740
|
| 112 |
Pervej Alom Barbhuiya, Smitakshi Talukdar, Simanta Jyoti Chetia, Matteo Radice, Manash Pratim Pathak. Role of dietary flavonoids in targeting MASLD by modulating oxidative, inflammatory, and lipogenesis pathways. PharmaNutrition 2026; 37 doi: 10.1016/j.phanu.2026.100520
|
| 113 |
Chencheng Xie, Christine Pocha. Crosstalk between Gut Microbiota and Hepatocellular Carcinoma. Gastrointestinal Disorders 2023; 5(2) doi: 10.3390/gidisord5020013
|
| 114 |
Parth J Parekh, Luis A Balart, David A Johnson. The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clinical and Translational Gastroenterology 2015; 6(6) doi: 10.1038/ctg.2015.16
|
| 115 |
Mingfei Yao, Lingling Qv, Yanmeng Lu, Baohong Wang, Björn Berglund, Lanjuan Li. An Update on the Efficacy and Functionality of Probiotics for the Treatment of Non-Alcoholic Fatty Liver Disease. Engineering 2021; 7(5) doi: 10.1016/j.eng.2020.01.017
|
| 116 |
Yong Jiang, Tao Han, Zhi‐Guang Zhang, Man Li, Feng‐Xiang Qi, Ying Zhang, Ying‐Lan Ji. Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease. Chronic Diseases and Translational Medicine 2017; 3(3) doi: 10.1016/j.cdtm.2017.06.003
|
| 117 |
Stefano Bibbò, Gianluca Ianiro, Maria Pina Dore, Claudia Simonelli, Estelle E. Newton, Giovanni Cammarota. Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease. Mediators of Inflammation 2018; 2018 doi: 10.1155/2018/9321643
|
| 118 |
Noha F. Hassan, Somaia A. Nada, Azza Hassan, Mona R. El-Ansary, Muhammad Y. Al-Shorbagy, Rania M. Abdelsalam. Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis. Inflammation 2019; 42(3) doi: 10.1007/s10753-019-00967-6
|
| 119 |
Yun Ji, Yue Yin, Ziru Li, Weizhen Zhang. Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients 2019; 11(8) doi: 10.3390/nu11081712
|
| 120 |
Yi Xia, Mengting Ren, Jinpu Yang, Changzhou Cai, Weixin Cheng, Xinxin Zhou, Dan Lu, Feng Ji. Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.1003755
|
| 121 |
Craig James McClain, Laura Smart, Sarah Safadi, Irina Kirpich. Present Knowledge in Nutrition. 2020; doi: 10.1016/B978-0-12-818460-8.00026-5
|
| 122 |
Hamed Ebrahimzadeh Leylabadlo, Sarvin Sanaie, Fatemah Sadeghpour Heravi, Zainab Ahmadian, Reza Ghotaslou. From role of gut microbiota to microbial-based therapies in type 2-diabetes. Infection, Genetics and Evolution 2020; 81 doi: 10.1016/j.meegid.2020.104268
|
| 123 |
Zhongbo Liu, Jose Cordoba-Chacon, Rhonda D. Kineman, Bruce N. Cronstein, Radhika Muzumdar, Zhenwei Gong, Haim Werner, Shoshana Yakar. Growth Hormone Control of Hepatic Lipid Metabolism. Diabetes 2016; 65(12) doi: 10.2337/db16-0649
|
| 124 |
Wang Gu, Kang Wen, Chunchi Yan, Shuo Li, Tongjun Liu, Cheng Xu, Long Liu, Minmeng Zhao, Jun Zhang, Tuoyu Geng, Daoqing Gong. Maintaining intestinal structural integrity is a potential protective mechanism against inflammation in goose fatty liver. Poultry Science 2020; 99(11) doi: 10.1016/j.psj.2020.08.052
|
| 125 |
Tian-Hui Gao, Wan Liao, Li-Ting Lin, Zong-Ping Zhu, Mei-Gui Lu, Chao-Mei Fu, Tian Xie. Curcumae rhizoma and its major constituents against hepatobiliary disease: Pharmacotherapeutic properties and potential clinical applications. Phytomedicine 2022; 102 doi: 10.1016/j.phymed.2022.154090
|
| 126 |
Shuhua Shen, Kungen Wang, Yihui Zhi, Wei Shen, Liquan Huang. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway. Cell Cycle 2020; 19(22) doi: 10.1080/15384101.2020.1829800
|
| 127 |
Luca Maroni, Francesca Fianchi, Luca Miele, Gianluca Svegliati Baroni. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes. 2021; doi: 10.1016/B978-0-12-821927-0.00002-4
|
| 128 |
O. S. Oynotkinova, E. L. Nikonov, T. Y. Demidova, A. P. Baranov, E. V. Kryukov, E. I. Dedov, E. A. Karavashkina. Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics in their prevention. Terapevticheskii arkhiv 2020; 92(9) doi: 10.26442/00403660.2020.09.000784
|
| 129 |
Otilia Elena Frăsinariu, Violeta Ștreangă, Aniela Luminița Rugină, Dana Elena Mîndru, Teodora Cristina Vintilă, Oana Viola Bădulescu, Iris Bararu-Bojan, Vasile Valeriu Lupu, Ancuța Lupu, Adriana Mihai, Isabela Ioana Loghin, Daniela Eugenia Popescu, Dragoș Florin Teșoi. Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease: From Dysbiosis to Metagenomic Insights and Therapeutic Perspectives. Pharmaceuticals 2026; 19(7) doi: 10.3390/ph19071113
|
| 130 |
Zofia Prokopowicz, Ewa Malecka-Tendera, Pawel Matusik. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children. Canadian Journal of Gastroenterology and Hepatology 2018; 2018 doi: 10.1155/2018/9465784
|
| 131 |
Chencheng Xie, Dina Halegoua-DeMarzio. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?. Nutrients 2019; 11(11) doi: 10.3390/nu11112837
|
| 132 |
Masum M. Mia, Manvendra K. Singh. Emerging roles of the Hippo signaling pathway in modulating immune response and inflammation‐driven tissue repair and remodeling. The FEBS Journal 2022; 289(14) doi: 10.1111/febs.16449
|
| 133 |
Nádia Duarte, Inês C. Coelho, Rita S. Patarrão, Joana I. Almeida, Carlos Penha-Gonçalves, M. Paula Macedo. How Inflammation Impinges on NAFLD: A Role for Kupffer Cells. BioMed Research International 2015; 2015 doi: 10.1155/2015/984578
|
| 134 |
Lijun Wang, Weiwei Zhou, Manyun Guo, Yiming Hua, Baihua Zhou, Xinyin Li, Xinxin Zhang, Jiakun Dong, Xiumei Yang, Yang Wang, Yue Wu, Jianqing She, Jianjun Mu. The gut microbiota is associated with clinical response to statin treatment in patients with coronary artery disease. Atherosclerosis 2021; 325 doi: 10.1016/j.atherosclerosis.2021.03.007
|
| 135 |
Zhu Ming, Xie Ruishi, Xu Linyi, Yang Yonggang, Luo Haoming, Lan Xintian. The gut-liver axis in fatty liver disease: role played by natural products. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1365294
|
| 136 |
Sayantan Mukherjee, Aditi Chopra, Shaswata Karmakar, Subraya Giliyar Bhat. Periodontitis increases the risk of gastrointestinal dysfunction: an update on the plausible pathogenic molecular mechanisms. Critical Reviews in Microbiology 2025; 51(1) doi: 10.1080/1040841X.2024.2339260
|
| 137 |
Jacques Delarue, Jean‐Paul Lallès. Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long‐chain n‐3 PUFA. Molecular Nutrition & Food Research 2016; 60(1) doi: 10.1002/mnfr.201500346
|
| 138 |
Natalia Nuño-Lámbarri, Norberto C. Chávez-Tapia, Misael Uribe. Encyclopedia of Food Chemistry. 2019; doi: 10.1016/B978-0-08-100596-5.21759-9
|
| 139 |
Wei Song, Tianyi Wang, Xiaole Cui, Lingling Li, Bing Chen, Yanjie Li, Tianli Yue. Lactobacillus coryniformis subsp. torquensT3 alleviates non‐alcoholic fatty liver disease via reconstruction of the gut microbiota and redox system. Journal of the Science of Food and Agriculture 2023; 103(14) doi: 10.1002/jsfa.12774
|
| 140 |
Cynthia Aparecida de Castro, Manoela Maciel dos Santos Dias, Karina Ana da Silva, Sandra Aparecida dos Reis, Lisiane Lopes da Conceição, Letícia De Nadai Marcon, Luis Fernando de Sousa Moraes, Maria do Carmo Gouveia Peluzio. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; doi: 10.1007/978-94-007-7675-3_1
|
| 141 |
Shifeng Fu, Mengmeng Xu, Jianglei Li, Meihong Yu, Siyi Wang, Liu Han, Rong Li, Feihong Deng, Hailing Peng, Deliang Liu, Yuyong Tan. HDAC6 inhibitor ACY-1215 protects from nonalcoholic fatty liver disease via inhibiting CD14/TLR4/MyD88/MAPK/NFκB signal pathway. Heliyon 2024; 10(13) doi: 10.1016/j.heliyon.2024.e33740
|
| 142 |
Miaoqing Ye, Yinghui Tang, Jinyu He, Yueqing Yang, Xueyan Cao, Shaojie Kou, Lin Wang, Lingli Sheng, Jingdong Xue. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway. Clínica e Investigación en Arteriosclerosis (English Edition) 2021; 33(5) doi: 10.1016/j.artere.2021.09.001
|
| 143 |
Chunwei Cheng, Jun Tan, Wei Qian, Lei Zhang, Xiaohua Hou. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction. Life Sciences 2018; 209 doi: 10.1016/j.lfs.2018.08.017
|
| 144 |
Branka Filipovic, Snezana Lukic, Dragana Mijac, Marija Marjanovic-Haljilji, Marko Vojnovic, Jelena Bogdanovic, Tijana Glisic, Natasa Filipovic, Jamal Al Kiswani, Aleksandra Djokovic, Suncica Kapor, Slobodan Kapor, Zoran Bukumiric, Ana Starcevic. The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(24) doi: 10.3390/ijms222413219
|
| 145 |
Yang Li, Chunmei Bai, Xumin Zhang, Haixia Song, Peiyue Yu, Jianrong Liu. Microplastic exposure is associated with gut microbiota alterations, intestinal barrier impairment, and endotoxin-related inflammation in female rats. Current Research in Toxicology 2026; doi: 10.1016/j.crtox.2026.100316
|
| 146 |
Jianyi Calvin Koh, Wai Mun Loo, Khean Lee Goh, Kentaro Sugano, Wah Kheong Chan, Wai Yan Philip Chiu, Myung‐Gyu Choi, Sutep Gonlachanvit, Wei‐Jei Lee, Wei Jie Jonathan Lee, Yeong Yeh Lee, Laurentius A Lesmana, You‐Ming Li, Chun Jen Liu, Bunzo Matsuura, Atsushi Nakajima, Enders Kwok Wai Ng, Jose D Sollano, Simon Kin Hung Wong, Vincent W S Wong, Yunsheng Yang, Khek Yu Ho, Yock Young Dan. Asian consensus on the relationship between obesity and gastrointestinal and liver diseases. Journal of Gastroenterology and Hepatology 2016; 31(8) doi: 10.1111/jgh.13385
|
| 147 |
Yihan Qian, Jie Zhao, Hailong Wu, Xiaoni Kong. Innate immune regulation in inflammation resolution and liver regeneration in drug-induced liver injury. Archives of Toxicology 2025; 99(1) doi: 10.1007/s00204-024-03886-0
|
| 148 |
Benedikt Kaufmann, Nick Seyfried, Daniel Hartmann, Phillipp Hartmann. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 325(1) doi: 10.1152/ajpgi.00017.2023
|
| 149 |
Hessam Yaghmaei, Seyed Ali Nojoumi, Masood Soltanipur, Hossein Yarmohammadi, Seyed Mohsen Mirhosseini, Mahdi Rezaei, Mohammadreza Jalali Nadoushan, Seyed Davar Siadat. The role of gut microbiota in non-alcoholic fatty liver disease pathogenesis. Obesity Medicine 2024; 50 doi: 10.1016/j.obmed.2024.100551
|
| 150 |
José Manuel Rubio-Gómez, Carlos Molina Santiago, Zulema Udaondo, Mireia Tena Garitaonaindia, Tino Krell, Juan-Luis Ramos, Abdelali Daddaoua. Full Transcriptomic Response of Pseudomonas aeruginosa to an Inulin-Derived Fructooligosaccharide. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.00202
|
| 151 |
Xiao-Jing Zhang, Peng Zhang, Hongliang Li. Interferon Regulatory Factor Signalings in Cardiometabolic Diseases. Hypertension 2015; 66(2) doi: 10.1161/HYPERTENSIONAHA.115.04898
|
| 152 |
Dandan Tian, Yihan Yu, Yingying Yu, Lingzheng Lu, Difei Tong, Weixia Zhang, Xunyi Zhang, Wei Shi, Guangxu Liu. Tris(2-chloroethyl) Phosphate Exerts Hepatotoxic Impacts on Zebrafish by Disrupting Hypothalamic–Pituitary–Thyroid and Gut–Liver Axes. Environmental Science & Technology 2023; 57(24) doi: 10.1021/acs.est.3c01631
|
| 153 |
Simona Iacob, Diana Gabriela Iacob. Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01676
|
| 154 |
. 2018; doi: 10.70675/e7846b49z2785z4c33zb1a9z450ef2d17626
|
| 155 |
Esther Nistal, Luis E. Sáenz de Miera, María Ballesteros Pomar, Sonia Sánchez Campos, María Victoria García Mediavilla, Begoña Álvarez Cuenllas, Pedro Linares, José Luis Olcoz, María Teresa Arias Loste, Juan María García Lobo, Javier Crespo, Javier González Gallego, Francisco Jorquera Plaza. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity. Revista Española de Enfermedades Digestivas 2019; 111 doi: 10.17235/reed.2019.6068/2018
|
| 156 |
. 2022; doi: 10.70675/9d9521bazf006z45a9z99e7z46894f7d43c4
|
| 157 |
Swadha Anand, Sharmila S. Mande. Host-microbiome interactions: Gut-Liver axis and its connection with other organs. npj Biofilms and Microbiomes 2022; 8(1) doi: 10.1038/s41522-022-00352-6
|
| 158 |
. 2018; doi: 10.70675/bce7a140z3574z43dbza40ez1cd3403ed525
|
| 159 |
Parneet Kaur, LisaF.M LeeNenThat, Saurabh Kulshreshtha, Jessica Pandohee. The Gut Microbiota in Health and Disease. 2023; doi: 10.1002/9781119904786.ch13
|
| 160 |
Xiao-Lin Liu, Ya-Nan Ming, Jing-Yi Zhang, Xiao-Yu Chen, Min-De Zeng, Yi-Min Mao. Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes. Experimental & Molecular Medicine 2017; 49(1) doi: 10.1038/emm.2016.123
|
| 161 |
Gaolong Zhong, Fang Wan, Juan Lan, Xuanxuan Jiang, Shaofeng Wu, Jiaqiang Pan, Zhaoxin Tang, Lianmei Hu. Arsenic exposure induces intestinal barrier damage and consequent activation of gut-liver axis leading to inflammation and pyroptosis of liver in ducks. Science of The Total Environment 2021; 788 doi: 10.1016/j.scitotenv.2021.147780
|
| 162 |
Fei Wang, Nan‐nan Sun, Lan‐lan Li, Wan‐wan Zhu, Jianbo Xiu, Yan Shen, Qi Xu. Hepatic progenitor cell activation is induced by the depletion of the gut microbiome in mice. MicrobiologyOpen 2019; 8(10) doi: 10.1002/mbo3.873
|
| 163 |
裕梅 范. Research Progress on Rifaximin in Modulating Gut Microbiota for the Treatment of Nonalcoholic Fatty Liver Disease. Advances in Clinical Medicine 2025; 15(01) doi: 10.12677/acm.2025.151161
|
| 164 |
. 2020; doi: 10.70675/282e9d85z4f3dz4f5bz9045zd1ce6da72037
|
| 165 |
Irene Pierantonelli, Gianluca Svegliati-Baroni. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH. Transplantation 2019; 103(1) doi: 10.1097/TP.0000000000002480
|
| 166 |
Chunyu Guo, Qingjun Li, Rihong Chen, Wenhui Fan, Xin Zhang, Yuqian Zhang, Lanping Guo, Xiao Wang, Xinyan Qu, Hongjing Dong. Baicalein alleviates non-alcoholic fatty liver disease in mice by ameliorating intestinal barrier dysfunction. Food & Function 2023; 14(4) doi: 10.1039/D2FO03015B
|
| 167 |
Kwang Hwa Jung, Wonbeak Yoo, Heather L. Stevenson, Dipti Deshpande, Hong Shen, Mihai Gagea, Suk-Young Yoo, Jing Wang, T. Kris Eckols, Uddalak Bharadwaj, David J. Tweardy, Laura Beretta. Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice. Clinical Cancer Research 2017; 23(18) doi: 10.1158/1078-0432.CCR-16-2253
|
| 168 |
Sebastian J. Wallace, Frank Tacke, Robert F. Schwabe, Neil C. Henderson. Understanding the cellular interactome of non-alcoholic fatty liver disease. JHEP Reports 2022; 4(8) doi: 10.1016/j.jhepr.2022.100524
|
| 169 |
Laia Bertran, Rosa Jorba-Martin, Andrea Barrientos-Riosalido, Marta Portillo-Carrasquer, Carmen Aguilar, David Riesco, Salomé Martínez, Margarita Vives, Fàtima Sabench, Daniel Del Castillo, Cristóbal Richart, Teresa Auguet. New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(13) doi: 10.3390/ijms23137442
|
| 170 |
Victor Hugo Dantas Guimarães, Barbhara Mota Marinho, Daisy Motta-Santos, Gabriela da Rocha Lemos Mendes, Sérgio Henrique Sousa Santos. Nutritional implications in the mechanistic link between the intestinal microbiome, renin-angiotensin system, and the development of obesity and metabolic syndrome. The Journal of Nutritional Biochemistry 2023; 113 doi: 10.1016/j.jnutbio.2022.109252
|
| 171 |
Arpita Arora, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Eduardo Sobarzo-Sanchez, Simona Bungau. Unravelling the involvement of gut microbiota in type 2 diabetes mellitus. Life Sciences 2021; 273 doi: 10.1016/j.lfs.2021.119311
|
| 172 |
Junyan Tao, Linxuan Tian, Qinyuan Yang, Yao Jiang, Yubo Liu, Junli Wang, Xiong Chen, Hui Gao. Benzophenone-3 remodels gut microbiota diet-dependently to exacerbate non-alcoholic fatty liver disease in zebrafish. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1694753
|
| 173 |
Ting Qiu, Weitao Hu, Zilan Rao, Taiyong Fang. The molecular basis of the associations between non-alcoholic fatty liver disease and colorectal cancer. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.1007337
|
| 174 |
Zulema Udaondo, Kelsey Aguirre Schilder, Ana Rosa Márquez Blesa, Mireia Tena-Garitaonaindia, José Canto Mangana, Abdelali Daddaoua. Transcriptional Regulatory Systems in Pseudomonas: A Comparative Analysis of Helix-Turn-Helix Domains and Two-Component Signal Transduction Networks. International Journal of Molecular Sciences 2025; 26(10) doi: 10.3390/ijms26104677
|
| 175 |
Laura J. Craven, Seema Nair Parvathy, Jeremy P. Burton, Michael S. Silverman. Response to Ianiro et al.. American Journal of Gastroenterology 2021; 116(6) doi: 10.14309/ajg.0000000000001160
|
| 176 |
Elizabeth C Verna. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV. The Lancet Gastroenterology & Hepatology 2017; 2(3) doi: 10.1016/S2468-1253(16)30120-0
|
| 177 |
Asmaa M. Elshaer, Omnyah A. El-kharashi, Ghada Galal Hamam, Enas S. Nabih, Yosra M. Magdy, Abeer A. Abd El Samad. Involvement of TLR4/ CXCL9/ PREX-2 pathway in the development of hepatocellular carcinoma (HCC) and the promising role of early administration of lactobacillus plantarum in Wistar rats. Tissue and Cell 2019; 60 doi: 10.1016/j.tice.2019.07.010
|
| 178 |
Wangxin Liu, Xianliang Luo, Jun Tang, Qiufen Mo, Hao Zhong, Hui Zhang, Fengqin Feng. A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier. European Journal of Nutrition 2021; 60(5) doi: 10.1007/s00394-020-02431-w
|
| 179 |
Noha F. Hassan, Azza H. Hassan, Mona R. El-Ansary. Cytokine modulation by etanercept ameliorates metabolic syndrome and its related complications induced in rats administered a high-fat high-fructose diet. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24593-9
|
| 180 |
B. Fatemeh Nobakht M. Gh, Yazdan Hasani Nourian, Masoud Arabfard. Identification of Shared Gene Signatures in Different Stages of Nonalcoholic Fatty Liver Disease Using Integrated Microarray Datasets. Hepatitis Monthly 2022; 22(1) doi: 10.5812/hepatmon-122362
|
| 181 |
Chenwei Song, Wei Lv, Yahui Li, Pan Nie, Jun Lu, Yanlou Geng, Zhang Heng, Lihua Song. Alleviating the effect of quinoa and the underlying mechanism on hepatic steatosis in high-fat diet-fed rats. Nutrition & Metabolism 2021; 18(1) doi: 10.1186/s12986-021-00631-7
|
| 182 |
Miaoqing Ye, Yinghui Tang, Jinyu He, Yueqing Yang, Xueyan Cao, Shaojie Kou, Lin Wang, Lingli Sheng, Jingdong Xue. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway. Clínica e Investigación en Arteriosclerosis 2021; 33(5) doi: 10.1016/j.arteri.2020.12.007
|
| 183 |
Jung A Eom, Goo Hyun Kwon, Na Yeon Kim, Eun Ju Park, Sung Min Won, Jin Ju Jeong, Ganesan Raja, Haripriya Gupta, Yoseph Asmelash Gebru, Satyapriya Sharma, Ye Rin Choi, Hyeong Seop Kim, Sang Jun Yoon, Ji Ye Hyun, Min Kyo Jeong, Hee Jin Park, Byeong Hyun Min, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk. Diet-Regulating Microbiota and Host Immune System in Liver Disease. International Journal of Molecular Sciences 2021; 22(12) doi: 10.3390/ijms22126326
|
| 184 |
Shengan Zhang, Yanqi Dang. Roles of gut microbiota and metabolites in overweight and obesity of children. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.994930
|
| 185 |
Meiyu Jin, Lianwen Zheng, Yunfei Wei, Jiaqi Cheng, Di Zhang, Siru Yan, Haiyan Qin, Qi Wang, Xinxin Ci, Haihua Feng. Enterobacter cloacae aggravates metabolic disease by inducing inflammation and lipid accumulation. Environmental Toxicology and Pharmacology 2022; 90 doi: 10.1016/j.etap.2022.103819
|
| 186 |
|
| 187 |
Muzahir Hussain, Muhammad Umair Ijaz, Muhammad Ijaz Ahmad, Iftikhar Ali Khan, Syed Umar Farooq Bukhary, Waqar Khan, Sayed Hussain, Majid Suhail Hashmi, Chunbao Li. Gut inflammation exacerbates hepatic injury in C57BL/6J mice via gut-vascular barrier dysfunction with high-fat-incorporated meat protein diets. Food & Function 2020; 11(10) doi: 10.1039/D0FO02153A
|
| 188 |
Wenwen Sun, Jiahao Zhu, Guanyu Qin, Yujie Huang, Siying Cheng, Zhengzhi Chen, Yeyang Zhang, Yifan Shu, Xiaoxiong Zeng, Renpeng Guo. Lonicera japonica polysaccharides alleviate D-galactose-induced oxidative stress and restore gut microbiota in ICR mice. International Journal of Biological Macromolecules 2023; 245 doi: 10.1016/j.ijbiomac.2023.125517
|
| 189 |
R.X. Wei, F.J. Ye, F. He, Q. Song, X.P. Xiong, W.L. Yang, X. Gang, J.W. Hu, B. Hu, H.Y. Xu, L. Li, H.H. Liu, X.Y. Zeng, L. Chen, B. Kang, C.C. Han. Comparison of overfeeding effects on gut physiology and microbiota in two goose breeds. Poultry Science 2021; 100(3) doi: 10.1016/j.psj.2020.12.057
|
| 190 |
Tze Mun Loo, Fumitaka Kamachi, Yoshihiro Watanabe, Shin Yoshimoto, Hiroaki Kanda, Yuriko Arai, Yaeko Nakajima-Takagi, Atsushi Iwama, Tomoaki Koga, Yukihiko Sugimoto, Takayuki Ozawa, Masaru Nakamura, Miho Kumagai, Koichi Watashi, Makoto M. Taketo, Tomohiro Aoki, Shuh Narumiya, Masanobu Oshima, Makoto Arita, Eiji Hara, Naoko Ohtani. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity. Cancer Discovery 2017; 7(5) doi: 10.1158/2159-8290.CD-16-0932
|
| 191 |
Shuwei Zhang, Yui-Tung Wong, Ka-Yu Tang, Hiu-Yee Kwan, Tao Su. Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.572729
|
| 192 |
Waleed Alghamdi, Mahmoud Mosli, Saleh A. Alqahtani. Gut microbiota in MAFLD: therapeutic and diagnostic implications. Therapeutic Advances in Endocrinology and Metabolism 2024; 15 doi: 10.1177/20420188241242937
|
| 193 |
Zhaojiong Zhang, Wenjing Hu, Aiqi Yu, Haizheng Bi, Jingyuan Wang, Xingyu Wang, Haixue Kuang, Meng Wang. Physicochemical properties, health benefits, and applications of the polysaccharides from Rosa rugosa Thunb.: A review. International Journal of Biological Macromolecules 2024; 282 doi: 10.1016/j.ijbiomac.2024.136975
|
| 194 |
David Porras, Esther Nistal, Susana Martínez‐Flórez, José Luis Olcoz, Ramiro Jover, Francisco Jorquera, Javier González‐Gallego, María Victoria García‐Mediavilla, Sonia Sánchez‐Campos. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High‐Fat Diet Determine Non‐Alcoholic Fatty Liver Disease Development in Germ‐Free Mice. Molecular Nutrition & Food Research 2019; 63(8) doi: 10.1002/mnfr.201800930
|
| 195 |
Jasmeet S. Mokha, Zev H. Davidovics, Kendra Maas, Melissa J. Caimano, Adam Matson. Fecal Microbiomes in Premature Infants With and Without Parenteral Nutrition–Associated Cholestasis. Journal of Pediatric Gastroenterology and Nutrition 2019; 69(2) doi: 10.1097/MPG.0000000000002352
|
| 196 |
Celeste M. Lavallee, Jayden A. R. MacPherson, Mi Zhou, Yanhua Gao, Pamela R. Wizzard, Paul W. Wales, Justine M. Turner, Benjamin P. Willing. Lipid Emulsion Formulation of Parenteral Nutrition Affects Intestinal Microbiota and Host Responses in Neonatal Piglets. Journal of Parenteral and Enteral Nutrition 2017; 41(8) doi: 10.1177/0148607116662972
|
| 197 |
Yu Tian, Hualin Wang, Fahu Yuan, Na Li, Qiang Huang, Lei He, Limei Wang, Zhiguo Liu. Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut Dysbiosis. BioMed Research International 2016; 2016 doi: 10.1155/2016/9462571
|
| 198 |
Kouichi Miura, Mitsuaki Ishioka, Shinichiro Minami, Yasuo Horie, Shigetoshi Ohshima, Takashi Goto, Hirohide Ohnishi. Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice. Journal of Biological Chemistry 2016; 291(22) doi: 10.1074/jbc.M115.709048
|
| 199 |
Sanjoy Roychowdhury, Praveen Conjeevaram Selvakumar, Gail A.M. Cresci. The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. Medical Sciences 2018; 6(2) doi: 10.3390/medsci6020047
|
| 200 |
Ryan Kurtz, Meghan F. Anderman, Blythe D. Shepard. GPCRs get fatty: the role of G protein-coupled receptor signaling in the development and progression of nonalcoholic fatty liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(3) doi: 10.1152/ajpgi.00275.2020
|
| 201 |
Samradhi Singh, Mona Kriti, Roberto Catanzaro, Francesco Marotta, Mustafa Malvi, Ajay Jain, Vinod Verma, Ravinder Nagpal, Rajnarayan Tiwari, Manoj Kumar. Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease. Livers 2024; 4(3) doi: 10.3390/livers4030032
|
| 202 |
Costanza Renata Neri, Serena Scapaticci, Francesco Chiarelli, Cosimo Giannini. Liver Steatosis: A Marker of Metabolic Risk in Children. International Journal of Molecular Sciences 2022; 23(9) doi: 10.3390/ijms23094822
|
| 203 |
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Jun Kato, Shiho Tokunaga, Taka-aki Sugihara, Yuichi Hara, Keisuke Hino, Yoshikazu Murawaki, Gonzalo Carrasco-Avino. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model. PLOS ONE 2016; 11(5) doi: 10.1371/journal.pone.0154676
|
| 204 |
Xiuxia Li, Yanping Wang, Yilan Xing, Renxin Xing, Yongsheng Liu, Yinsheng Xu. Changes of gut microbiota during silybin‐mediated treatment of high‐fat diet‐induced non‐alcoholic fatty liver disease in mice. Hepatology Research 2020; 50(1) doi: 10.1111/hepr.13444
|
| 205 |
Chencheng Xie, Dina Halegoua-DeMarzio. The Role of Gut Microbiome-Targeted Therapy in Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2020; 19(4) doi: 10.1007/s11901-020-00547-5
|
| 206 |
Patrice Marques, Vera Francisco, Laura Martínez-Arenas, Ângela Carvalho-Gomes, Elena Domingo, Laura Piqueras, Marina Berenguer, Maria-Jesus Sanz. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(3) doi: 10.3390/ijms24032313
|
| 207 |
Sergio Quesada-Vázquez, Gerard Aragonès, Josep M Del Bas, Xavier Escoté. Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis. Cells 2020; 9(1) doi: 10.3390/cells9010176
|
| 208 |
Alexandre Villard, Jérôme Boursier, Ramaroson Andriantsitohaina. Microbiota‐derived extracellular vesicles and metabolic syndrome. Acta Physiologica 2021; 231(4) doi: 10.1111/apha.13600
|
| 209 |
|
| 210 |
WenJie Yang, Abdur Rahman Ansari, XiaoYu Niu, WeiHua Zou, MengQi Lu, Ling Dong, Fan Li, YanHong Chen, KeLi Yang, Hui Song. Interaction between gut microbiota dysbiosis and lung infection as gut-lung axis caused by Streptococcus suis in mouse model. Microbiological Research 2022; 261 doi: 10.1016/j.micres.2022.127047
|
| 211 |
Y. Ilan. Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression. Alimentary Pharmacology & Therapeutics 2016; 44(11-12) doi: 10.1111/apt.13833
|
| 212 |
Jiahuan Li, Xiaoling Deng, Tao Bai, Shuhan Wang, Qianqian Jiang, Keshu Xu. Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88‐mediated NF‐κB and MAPK pathways and activating the Nrf2 pathway in mice. International Immunopharmacology 2020; 88 doi: 10.1016/j.intimp.2020.106961
|
| 213 |
Branka Filipovic, Marija Marjanovic-Haljilji, Dragana Mijac, Snezana Lukic, Suncica Kapor, Slobodan Kapor, Ana Starcevic, Dusan Popovic, Aleksandra Djokovic. Molecular Aspects of MAFLD—New Insights on Pathogenesis and Treatment. Current Issues in Molecular Biology 2023; 45(11) doi: 10.3390/cimb45110573
|
| 214 |
Aviva Fraer, Sanaz Saleh, Dana Tasabehji, Durga Shankar Sharma, Mohamad Mokadem. Neuroendocrine-immune perturbations in metabolic disease: pathophysiological mechanisms underlying cognitive impairment. Frontiers in Human Neuroscience 2026; 20 doi: 10.3389/fnhum.2026.1857087
|
| 215 |
Rui Jia, Li-Ping Cao, Jin-Liang Du, Qin He, Zheng-Yan Gu, Galina Jeney, Pao Xu, Guo-Jun Yin. Effects of high-fat diet on antioxidative status, apoptosis and inflammation in liver of tilapia (Oreochromis niloticus) via Nrf2, TLRs and JNK pathways. Fish & Shellfish Immunology 2020; 104 doi: 10.1016/j.fsi.2020.06.025
|
| 216 |
Wei Song, Li-Ying Sun, Zhi-Jun Zhu, Lin Wei, Wei Qu, Zhi-Gui Zeng, Yun-Sheng Yang. Characteristics of Gut Microbiota in Children With Biliary Atresia After Liver Transplantation. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.704313
|
| 217 |
Geoffrey C. Farrell, Fahrettin Haczeyni, Shivakumar Chitturi. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061 doi: 10.1007/978-981-10-8684-7_3
|
| 218 |
Rigaiqiqige Sa, Chi Feng, Hongxia Bai, Xiaoyu Yin, Lei Song, Xiaodong Hu, Rui Xu, Xinshan Li, Wu Dong, Jingfeng Yang, Jelena Zivkovic. Inhibitory Effects of Mongolian Medicine Yihe-Tang on Continuous Darkness Induced Liver Steatosis in Zebrafish. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/5794655
|
| 219 |
Rabab Fouad Emam, Ahmed Fouad Soliman, Samar Kamal Darweesh, Reham AbdElmoniem AbdElmagid, Ola Mohamed Ibrahim, Dina Mahmoud Mohamed. Steatosis regression assessed by cap after Vitamin ‘D’ supplementation in NAFLD patients with Vitamin ‘D’ deficiency. European Journal of Gastroenterology & Hepatology 2024; 36(1) doi: 10.1097/MEG.0000000000002653
|
| 220 |
Ahmed M. Samy, Mohamed A. Kandeil, Dina Sabry, A. A. Abdel‐Ghany, Mohamed O. Mahmoud. Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway. Archiv der Pharmazie 2024; 357(4) doi: 10.1002/ardp.202300631
|
| 221 |
Jiang Du, Yu Ji, Liang Qiao, Yanli Liu, Juntang Lin. Cellular endo‐lysosomal dysfunction in the pathogenesis of non‐alcoholic fatty liver disease. Liver International 2020; 40(2) doi: 10.1111/liv.14311
|
| 222 |
Katharina Brandl, Bernd Schnabl. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?. Expert Review of Gastroenterology & Hepatology 2015; 9(8) doi: 10.1586/17474124.2015.1057122
|
| 223 |
Gao-Xin Xu, Song Wei, Chao Yu, Si-Qi Zhao, Wei-Jun Yang, Yong-Heng Feng, Chao Pan, Kun-Xing Yang, Yong Ma. Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1199519
|
| 224 |
Safak Kiziltas. Toll-like receptors in pathophysiology of liver diseases. World Journal of Hepatology 2016; 8(32): 1354-1369 doi: 10.4254/wjh.v8.i32.1354
|
| 225 |
Dabin Jeon, Vineet Singh, Tatsuya Unno. In vitro investigation of food effects on human gut microbiota. Journal of Applied Biological Chemistry 2021; 64(1) doi: 10.3839/jabc.2021.012
|
| 226 |
Hiroshi Fukui. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?. Diseases 2019; 7(4) doi: 10.3390/diseases7040058
|
| 227 |
Alix Bruneau, Jana Hundertmark, Adrien Guillot, Frank Tacke. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725390
|
| 228 |
Ya. M. Vakhrushev, A. P. Lukashevich, E. V. Suchkova. ASSOCIATION OF INTESTINAL BACTERIAL OVERGROWTH AND DISEASES OF HEPATOBIARY TRACT. The Russian Archives of Internal Medicine 2019; 9(1) doi: 10.20514/2226-6704-2019-9-1-64-69
|
| 229 |
Danni Qu, Mengyun Chen, Haiyan Zhu, Xingyu Liu, Yanan Cui, Wei Zhou, Min Zhang. Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in mice. Biochemical and Biophysical Research Communications 2023; 684 doi: 10.1016/j.bbrc.2023.149131
|
| 230 |
Mariana Verdelho Machado, Anna Mae Diehl. Pathogenesis of Nonalcoholic Steatohepatitis. Gastroenterology 2016; 150(8) doi: 10.1053/j.gastro.2016.02.066
|
| 231 |
Eman Kolieb, Shymaa Ahmed Maher, Mohammed Nader Shalaby, Amnah Mohammed Alsuhaibani, Afaf Alharthi, Wael A. Hassan, Karima El-Sayed. Vitamin D and Swimming Exercise Prevent Obesity in Rats under a High-Fat Diet via Targeting FATP4 and TLR4 in the Liver and Adipose Tissue. International Journal of Environmental Research and Public Health 2022; 19(21) doi: 10.3390/ijerph192113740
|
| 232 |
Erica Vetrano, Luca Rinaldi, Andrea Mormone, Chiara Giorgione, Raffaele Galiero, Alfredo Caturano, Riccardo Nevola, Raffaele Marfella, Ferdinando Carlo Sasso. Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies. Biomedicines 2023; 11(2) doi: 10.3390/biomedicines11020468
|
| 233 |
Eric Zhao, Christopher Tait, Carlos D. Minacapelli, Carolyn Catalano, Vinod K. Rustgi. Circadian Rhythms, the Gut Microbiome, and Metabolic Disorders. Gastro Hep Advances 2022; 1(1) doi: 10.1016/j.gastha.2021.10.008
|
| 234 |
Jhon Edison Prieto Ortíz, Carlos Bernardo Sánchez Luque, Rolando José Ortega Quiróz. Hígado graso (parte 1): aspectos generales, epidemiología, fisiopatología e historia natural. Revista colombiana de Gastroenterología 2022; 37(4) doi: 10.22516/25007440.952
|
| 235 |
Qixing Nie, Xi Luo, Kai Wang, Yong Ding, Shumi Jia, Qixiang Zhao, Meng Li, Jinxin Zhang, Yingying Zhuo, Jun Lin, Chenghao Guo, Zhiwei Zhang, Huiying Liu, Guangyi Zeng, Jie You, Lulu Sun, Hua Lu, Ming Ma, Yanxing Jia, Ming-Hua Zheng, Yanli Pang, Jie Qiao, Changtao Jiang. Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway. Cell 2024; 187(11) doi: 10.1016/j.cell.2024.03.034
|
| 236 |
Hamed Ebrahimzadeh Leylabadlo, Reza Ghotaslou, Hossein Samadi Kafil, Mohammad Mehdi Feizabadi, Seyed Yaghoub Moaddab, Safar Farajnia, Elham Sheykhsaran, Sarvin Sanaie, Dariush Shanehbandi, Hossein Bannazadeh Baghi. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39(4) doi: 10.1007/s10096-019-03746-1
|
| 237 |
Shuhua Shen, Kungen Wang, Yihui Zhi, Yue Dong. Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways. Pharmaceutical Biology 2022; 60(1) doi: 10.1080/13880209.2022.2126503
|
| 238 |
Qihan Wang, Qifan Lu, Wentao Shao, Zhaoyan Jiang, Hai Hu. Dysbiosis of gut microbiota after cholecystectomy is associated with non‐alcoholic fatty liver disease in mice. FEBS Open Bio 2021; 11(8) doi: 10.1002/2211-5463.13243
|
| 239 |
Linlin Chen, Juntao Kan, Ningning Zheng, Bingbing Li, Ying Hong, Juan Yan, Xin Tao, Gaosong Wu, Junli Ma, Weize Zhu, Lili Sheng, Liang Chen, Bo Li, Jing Zhong, Jun Du, Houkai Li. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation. Phytomedicine 2021; 91 doi: 10.1016/j.phymed.2021.153693
|
| 240 |
Ya M Vakhrushev, E V Suchkova, A P Lukashevich. Non - alcoholic fatty liver disease and enteral insufficiency: comorbidity of their development. Terapevticheskii arkhiv 2019; 91(12) doi: 10.26442/00403660.2019.12.000134
|
| 241 |
Ratnadeep Bhattacharjee, Kalyani Pathak, Jyotirmoy Das, Smita Bordoloi, Manash Pratim Pathak, Pervej Alom Barbhuiya, Riya Saikia. Therapeutic Potential of Gut Microbiota in Child Health. Anti-Infective Agents 2023; 21(4) doi: 10.2174/2211352521666230518115214
|
| 242 |
Che-Sheng Pai, Cheng-Yuan Wang, Wei-Wen Hung, Wei-Chun Hung, Hui-Ju Tsai, Chen-Chia Chang, Shang-Jyh Hwang, Chia-Yen Dai, Wen-Yu Ho, Yi-Chun Tsai. Interrelationship of Gut Microbiota, Obesity, Body Composition and Insulin Resistance in Asians with Type 2 Diabetes Mellitus. Journal of Personalized Medicine 2022; 12(4) doi: 10.3390/jpm12040617
|
| 243 |
Lu Wang, Bing Zhao, Ying Chen, Li Ma, Er-Zhen Chen, En-Qiang Mao. Biliary tract external drainage protects against intestinal barrier injury in hemorrhagic shock rats. World Journal of Gastroenterology 2015; 21(45): 12800-12813 doi: 10.3748/wjg.v21.i45.12800
|
| 244 |
Zeinab Harb, Valérie Deckert, Aude Marchal Bressenot, Christo Christov, Rosa-Maria Guéant-Rodriguez, Jérémie Raso, Jean Marc Alberto, Jean-Paul Pais de Barros, Remy Umoret, Laurent Peyrin-Biroulet, Laurent Lagrost, Jean-Pierre Bronowicki, Jean-Louis Guéant. The deficit in folate and vitamin B12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced colitis. The Journal of Nutritional Biochemistry 2020; 84 doi: 10.1016/j.jnutbio.2020.108415
|
| 245 |
Serena Scapaticci, Annamaria Venanzi, Francesco Chiarelli, Cosimo Giannini. MAFLD and Celiac Disease in Children. International Journal of Molecular Sciences 2023; 24(2) doi: 10.3390/ijms24021764
|
| 246 |
Yolanda Sanchez-Torrijos, Javier Ampuero, Manuel Romero-Gómez. Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do. World Journal of Hepatology 2017; 9(15): 697-703 doi: 10.4254/wjh.v9.i15.697
|
| 247 |
R. Wei, C. Han, D. Deng, F. Ye, X. Gan, H. Liu, L. Li, H. Xu, S. Wei. Research progress into the physiological changes in metabolic pathways in waterfowl with hepatic steatosis. British Poultry Science 2021; 62(1) doi: 10.1080/00071668.2020.1812527
|
| 248 |
Donald B. Jump, Kelli A. Lytle, Christopher M. Depner, Sasmita Tripathy. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. Pharmacology & Therapeutics 2018; 181 doi: 10.1016/j.pharmthera.2017.07.007
|
| 249 |
Tatsuo Inamine, Bernd Schnabl. Immunoglobulin A and liver diseases. Journal of Gastroenterology 2018; 53(6) doi: 10.1007/s00535-017-1400-8
|
| 250 |
Daniel Ferraz de Campos Mazo, Rejane Mattar, José Tadeu Stefano, Joyce Matie Kinoshita da Silva-Etto, Márcio Augusto Diniz, Sebastião Mauro Bezerra Duarte, Fabíola Rabelo, Rodrigo Vieira Costa Lima, Priscila Brizolla de Campos, Flair José Carrilho, Claudia P Oliveira. Hypolactasia is associated with insulin resistance in nonalcoholic steatohepatitis. World Journal of Hepatology 2016; 8(24): 1019-1027 doi: 10.4254/wjh.v8.i24.1019
|
| 251 |
玉杰 李. Relationship between Gut Microbiota and Development and Prognosis of Autoimmune Liver Disease. Advances in Clinical Medicine 2022; 12(11) doi: 10.12677/ACM.2022.12111557
|
| 252 |
Xuanwei Chen, Yang Xuan, Yawen Chen, Fanfan Yang, Mengying Zhu, Jian Xu, Jin Chen. Polystyrene nanoplastics induce intestinal and hepatic inflammation through activation of NF-κB/NLRP3 pathways and related gut-liver axis in mice. Science of The Total Environment 2024; 935 doi: 10.1016/j.scitotenv.2024.173458
|
| 253 |
Yihang Cai, Yongyi Chen, Xiqin Bian, Changlin Sun, Jing Cheng, Haibo Liu, Lai Jin, Jianxin Ma, Wentao Liu. Fucoidan alleviates chemotherapy-induced steatohepatitis by regulating the gut–liver axis. International Immunopharmacology 2026; 175 doi: 10.1016/j.intimp.2026.116390
|
| 254 |
José Pedro Portela-Cidade, Marta Borges-Canha, Adelino Ferreira Leite-Moreira, Pedro Pimentel-Nunes. Systematic Review of the Relation Between Intestinal Microbiota and Toll-Like Receptors in the Metabolic Syndrome: What Do We Know So Far?. GE Portuguese Journal of Gastroenterology 2015; 22(6) doi: 10.1016/j.jpge.2015.06.001
|
| 255 |
Snigdha Jyoti Das, Sangit Dutta, Diptika Tiwari, Tarun Kr Basumatary, Natasha Kashyap, Manash Pratim Kalita, Sujoy Bose, Purabi Deka Bose. Prognostic value of myeloid differentiation primary response protein 88 in type II diabetes mellitus in non-obese NAFLD: A case-control study from Assam. Human Gene 2024; 39 doi: 10.1016/j.humgen.2023.201246
|
| 256 |
Shaghayegh Khanmohammadi, Mohammad Shafi Kuchay. Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease. Pharmacological Research 2022; 185 doi: 10.1016/j.phrs.2022.106507
|
| 257 |
Qiaozhu Su, Virender Kumar, Neetu Sud, Ram I. Mahato. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Advanced Drug Delivery Reviews 2018; 129 doi: 10.1016/j.addr.2018.01.009
|
| 258 |
Ahmed Abdel-Razik, Nasser Mousa, Walaa Shabana, Mohamed Refaey, Rasha Elzehery, Rania Elhelaly, Khaled Zalata, Mostafa Abdelsalam, Ahmed A. Eldeeb, Mahmoud Awad, Ayman Elgamal, Ahmed Attia, Niveen El-Wakeel, Waleed Eldars. Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot. European Journal of Gastroenterology & Hepatology 2018; 30(10) doi: 10.1097/MEG.0000000000001232
|
| 259 |
Massimiliano Cadamuro, Alberto Lasagni, Samantha Sarcognato, Maria Guido, Roberto Fabris, Mario Strazzabosco, Alastair J. Strain, Paolo Simioni, Erica Villa, Luca Fabris. The Neglected Role of Bile Duct Epithelial Cells in NASH. Seminars in Liver Disease 2022; 42(01) doi: 10.1055/s-0041-1739455
|
| 260 |
Chen Yan, Cuili Zhang, Xuejiao Cao, Bin Feng, Xinli Li. Intestinal Population in Host with Metabolic Syndrome during Administration of Chitosan and Its Derivatives. Molecules 2020; 25(24) doi: 10.3390/molecules25245857
|
| 261 |
Nicolás Ortiz-López, Catalina Fuenzalida, María Soledad Dufeu, Araceli Pinto-León, Alejandro Escobar, Jaime Poniachik, Juan Pablo Roblero, Lucía Valenzuela-Pérez, Caroll J. Beltrán. The immune response as a therapeutic target in non-alcoholic fatty liver disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.954869
|
| 262 |
Carlos Sanz-García, Anabel Fernández-Iglesias, Jordi Gracia-Sancho, Luis Alfonso Arráez-Aybar, Yulia A. Nevzorova, Francisco Javier Cubero. The Space of Disse: The Liver Hub in Health and Disease. Livers 2021; 1(1) doi: 10.3390/livers1010002
|
| 263 |
Junli Ma, Houkai Li. The Role of Gut Microbiota in Atherosclerosis and Hypertension. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01082
|
| 264 |
Eveliina Munukka, Petri Wiklund, Tiina Partanen, Sakari Välimäki, Eija K. Laakkonen, Maarit Lehti, Pamela Fischer-Posovzsky, Martin Wabitsch, Sulin Cheng, Pentti Huovinen, Satu Pekkala, Pratibha V. Nerurkar. Adipocytes as a Link Between Gut Microbiota-Derived Flagellin and Hepatocyte Fat Accumulation. PLOS ONE 2016; 11(4) doi: 10.1371/journal.pone.0152786
|
| 265 |
Zhiruo Miao, Zhiying Miao, Min Liu, Shiwen Xu. Melatonin ameliorates imidacloprid-induced intestinal injury by negatively regulating the PGN/P38MAPK pathway in the common carp (Cyprinus carpio). Fish & Shellfish Immunology 2022; 131 doi: 10.1016/j.fsi.2022.11.018
|
| 266 |
Jiazhen Zheng, Ziyi Li, Hengyi Xu. Intestinal Microbiotas and Alcoholic Hepatitis: Pathogenesis and Therapeutic Value. International Journal of Molecular Sciences 2023; 24(19) doi: 10.3390/ijms241914809
|
| 267 |
Ying-Li Liu, Qiu-Zan Zhang, Yan-Rong Wang, Li-Na Fu, Jing-Shu Han, Jing Zhang, Bang-Mao Wang. Astragaloside IV Improves High-Fat Diet–Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.605064
|
| 268 |
Gianluca Svegliati-Baroni, Irene Pierantonelli, Pierangelo Torquato, Rita Marinelli, Carla Ferreri, Chryssostomos Chatgilialoglu, Desirée Bartolini, Francesco Galli. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease. Free Radical Biology and Medicine 2019; 144 doi: 10.1016/j.freeradbiomed.2019.05.029
|
| 269 |
Hessam Yaghmaei, Amirmahdi Taromiha, Seyed Ali Nojoumi, Masood Soltanipur, Sina Shahshenas, Mahdi Rezaei, Seyed Mohsen Mirhosseini, Seyyed Mohammad Hosseini, Seyed Davar Siadat. Role of Gut-Liver Axis in Non-Alcoholic Fatty Liver Disease: A Mini Review. Iranian Biomedical Journal 2025; 29(1) doi: 10.61882/ibj.4212
|
| 270 |
Aoxiang Zhuge, Shengjie Li, Pengcheng Lou, Wenrui Wu, Kaiceng Wang, Yin Yuan, Jiafeng Xia, Bo Li, Lanjuan Li, Yongjun Sui. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice. Microbiology Spectrum 2022; 10(3) doi: 10.1128/spectrum.00047-22
|
| 271 |
Nasrin Sharifi, Reza Amani. Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials. Critical Reviews in Food Science and Nutrition 2019; 59(4) doi: 10.1080/10408398.2017.1389693
|
| 272 |
Haichao Wang, Yaying Li, Yifei Bian, Xue Li, Yubei Wang, Ke Wu, Chuanguo Liu, Yuhong Liu, Xiaoming Wang. Potential hepatoprotective effects of Cistanche deserticola Y.C. Ma: Integrated phytochemical analysis using UPLC-Q-TOF-MS/MS, target network analysis, and experimental assessment. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1018572
|
| 273 |
Kai Markus Schneider, Antje Mohs, Konrad Kilic, Lena Susanna Candels, Carsten Elfers, Eveline Bennek, Lukas Ben Schneider, Felix Heymann, Nikolaus Gassler, John Penders, Christian Trautwein. Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis. International Journal of Molecular Sciences 2019; 20(2) doi: 10.3390/ijms20020308
|
| 274 |
Jiashu Li, Zeyang Qu, Feng Liu, Hao Jing, Yu Pan, Siyu Guo, Chun Loong Ho. Principles in Microbiome Engineering. 2022; doi: 10.1002/9783527825462.ch1
|
| 275 |
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Tomomitsu Matono, Jun Kato, Shiho Tokunaga, Takaaki Sugihara, Akira Hiramatsu, Hideyuki Hyogo, Hiroshi Tobita, Shuichi Sato, Miwa Kawanaka, Yuichi Hara, Keisuke Hino, Kazuaki Chayama, Yoshikazu Murawaki, Hajime Isomoto, Catherine Mounier. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease. PLOS ONE 2020; 15(2) doi: 10.1371/journal.pone.0219412
|
| 276 |
Parth J. Parekh, Edward C. Oldfield, David A. Johnson. The Effects of Sleep on the Commensal Microbiota. Journal of Clinical Gastroenterology 2018; 52(3) doi: 10.1097/MCG.0000000000000965
|
| 277 |
Paola Dongiovanni, Raffaela Rametta, Marica Meroni, Luca Valenti. The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development – a potential therapeutic target?. Expert Review of Gastroenterology & Hepatology 2016; 10(2) doi: 10.1586/17474124.2016.1110018
|
| 278 |
Yongqiang Teng, Rongxue Wei, Shanjing Peng, Jiang Li, Rong Ning, Zhaoyun Luo, Shouhai Wei, Lili Bai, Li Zhou, Chunchun Han. The integrative analysis of transcriptome and metabolome reveals differences in raw foie gras performance induced by different force-feeding intensities in male Tianfu meat geese. Frontiers in Veterinary Science 2025; 12 doi: 10.3389/fvets.2025.1653733
|
| 279 |
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
|
| 280 |
Fernando Bessone, María Valeria Razori, Marcelo G. Roma. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cellular and Molecular Life Sciences 2019; 76(1) doi: 10.1007/s00018-018-2947-0
|
| 281 |
Cosimo Giannini, Concetta Mastromauro, Serena Scapaticci, Cristina Gentile, Francesco Chiarelli. Role of bile acids in overweight and obese children and adolescents. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1011994
|
| 282 |
Marco Poeta, Luca Pierri, Pietro Vajro. Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease. Children 2017; 4(8) doi: 10.3390/children4080066
|
| 283 |
Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, Mario Masarone, Marcello Persico. Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.781567
|
| 284 |
Kyoungsub Song, Hyunjoo Kwon, Chang Han, Weina Chen, Jinqiang Zhang, Wenbo Ma, Srikanta Dash, Chandrashekhar R. Gandhi, Tong Wu. Yes‐Associated Protein in Kupffer Cells Enhances the Production of Proinflammatory Cytokines and Promotes the Development of Nonalcoholic Steatohepatitis. Hepatology 2020; 72(1) doi: 10.1002/hep.30990
|
| 285 |
Gege Tian, Wei Wang, Enrui Xia, Wenhui Chen, Shunzhen Zhang. Dendrobium officinale alleviates high-fat diet-induced nonalcoholic steatohepatitis by modulating gut microbiota. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1078447
|
| 286 |
Alfredo Larrosa-Haro, Erika A. Caro-Sabido. Secondary Malnutrition and Nutritional Intervention in Cholestatic Liver Diseases in Infants. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.716613
|
| 287 |
Suzan Attia Mawed, Mervat H. Ghoneim, Mayada R. Farag, Marwa S.H. Abdelmoety, Tamer Ahmed Ismail, Sheren A. Al-Zahaby. Aluminium nanoparticles (AL-NPs) caused gastrointestinal malformations, metabolic disorders and steatohepatitis in zebrafish larvae: Modulatory role of rosmarinic acid. Aquaculture Reports 2024; 39 doi: 10.1016/j.aqrep.2024.102489
|
| 288 |
C.C. Lu, R.X. Wei, D.H. Deng, Z.Y. Luo, M. Abdulai, H.H. Liu, B. Kang, S.Q. Hu, L. Li, H.Y. Xu, J.W. Hu, S.H. Wei, C.C. Han. Effect of different types of sugar on gut physiology and microbiota in overfed goose. Poultry Science 2021; 100(7) doi: 10.1016/j.psj.2021.101208
|
| 289 |
孟桥 陈. Progress on the Role of “Gutbacteria-Gut-Liver Axis” in Non-Alcoholic Fatty Liver Disease. Medical Diagnosis 2023; 13(02) doi: 10.12677/MD.2023.132038
|
| 290 |
Tatsuya Nakatani, Shinya Sato, Kosuke Kaji, Hiroki Kachi, Naoki Nishimura, Masafumi Oyama, Jun-ichi Hanatani, Satoshi Iwai, Soichi Takeda, Norihisa Nishimura, Koh Kitagawa, Tadashi Namisaki, Hitoshi Yoshiji. Bovine Milk-Derived Extracellular Vesicles Ameliorate Steatohepatitis by Restoring Gut Barrier in CDA-HFD-Fed Mice. International Journal of Molecular Sciences 2026; 27(14) doi: 10.3390/ijms27146485
|
| 291 |
Hyun Young Kim, Younggap Lim, Ji Sun Jang, Yeon Kyeong Ko, Youngnim Choi, Hong‐Hee Kim, Bong‐Kyu Choi. Extracellular vesicles from periodontal pathogens regulate hepatic steatosis via Toll‐like receptor 2 and plasminogen activator inhibitor‐1. Journal of Extracellular Vesicles 2024; 13(1) doi: 10.1002/jev2.12407
|
| 292 |
Mohsen Mazidi, Niki Katsiki, Dimitri P. Mikhailidis, Maciej Banach. Adiposity May Moderate the Link Between Choline Intake and Non-alcoholic Fatty Liver Disease. Journal of the American College of Nutrition 2019; 38(7) doi: 10.1080/07315724.2018.1507011
|
| 293 |
Thomas Ritz, Oliver Krenkel, Frank Tacke. Dynamic plasticity of macrophage functions in diseased liver. Cellular Immunology 2018; 330 doi: 10.1016/j.cellimm.2017.12.007
|
| 294 |
Shu-Hua Shen, Ting-Yan Zhong, Cui Peng, Jie Fang, Bin Lv. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats. BMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-2835-7
|
| 295 |
Junli Ma, Qihang Zhou, Houkai Li. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Nutrients 2017; 9(10) doi: 10.3390/nu9101124
|
| 296 |
Francesca Fianchi, Antonio Liguori, Antonio Gasbarrini, Antonio Grieco, Luca Miele. Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy. International Journal of Molecular Sciences 2021; 22(12) doi: 10.3390/ijms22126485
|
| 297 |
Lijun Wang, Yu-Jui Yvonne Wan. The role of gut microbiota in liver disease development and treatment. Liver Research 2019; 3(1) doi: 10.1016/j.livres.2019.02.001
|
| 298 |
Zelin Zhang, Huali chen, Qingwang Li. High-fat diet led to testicular inflammation and ferroptosis via dysbiosis of gut microbes. International Immunopharmacology 2024; 142 doi: 10.1016/j.intimp.2024.113235
|
| 299 |
Athina I. Amanatidou, George V. Dedoussis. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease. Computers in Biology and Medicine 2021; 131 doi: 10.1016/j.compbiomed.2021.104243
|
| 300 |
Sahar Y. Al-Okbi, Magdy A. Amin, Amal E. A. Mohamed, Amr E. Edris, Osama M. Sharaf, Hoda B Mabrok, Asmaa A. Ramadan. Basil Essential Oil and Its Nanoemulsion Mitigate Non Alcoholic Steatohepatitis in Rat Model with Special Reference to Gut Microbiota. Journal of Oleo Science 2020; 69(8) doi: 10.5650/jos.ess20067
|
| 301 |
Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology. 2018; doi: 10.1016/B978-0-323-37591-7.00025-2
|
| 302 |
Gaurab Bhaduri, Anchin Kalia, Banshi Saboo, Sanjay Bandyopadhyay. The Mitochondrial–Autophagy Axis in MASLD: Mechanisms, Crosstalk, and Therapeutic Targets. Comprehensive Physiology 2026; 16(3) doi: 10.1002/cph4.70155
|
| 303 |
Jing Xiong, Xia Chen, Zhijing Zhao, Ying Liao, Ting Zhou, Qian Xiang. A potential link between plasma short‑chain fatty acids, TNF‑α level and disease progression in non‑alcoholic fatty liver disease: A retrospective study. Experimental and Therapeutic Medicine 2022; 24(3) doi: 10.3892/etm.2022.11536
|
| 304 |
Junyu Luo, Xiaowen Jin, Mingyue Cui, Hanyu He, Jiabao Liao, Weibo Wen, Wenting Li, Yongjun Cao. Wulingsan alleviates metabolic dysfunction-associated steatotic liver disease through regulating gut microbiota-bile acid axis. Prostaglandins & Other Lipid Mediators 2026; 183 doi: 10.1016/j.prostaglandins.2026.107067
|
| 305 |
Veronika Vyletelová, Mária Nováková, Ľudmila Pašková. Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies. Pharmaceuticals 2022; 15(10) doi: 10.3390/ph15101278
|
| 306 |
Muhammad Y. Sheikh, Muhammad F. Younus, Annie Shergill, Muhammad N. Hasan. Diet and Lifestyle Interventions in Metabolic Dysfunction-Associated Fatty Liver Disease: A Comprehensive Review. International Journal of Molecular Sciences 2025; 26(19) doi: 10.3390/ijms26199625
|
| 307 |
Felipe Pinheiro de Oliveira, Roberta Hack Mendes, Priscila Thiago Dobbler, Volker Mai, Victor Salter Pylro, Sheldon G Waugh, Filippo Vairo, Lilia Farret Refosco, Luiz Fernando Würdig Roesch, Ida Vanessa Doederlein Schwartz, Brenda A Wilson. Phenylketonuria and Gut Microbiota: A Controlled Study Based on Next-Generation Sequencing. PLOS ONE 2016; 11(6) doi: 10.1371/journal.pone.0157513
|
| 308 |
Kavita Jadhav, Taylor S. Cohen. Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.592157
|
| 309 |
Ayse L. Mindikoglu, Antone R. Opekun, Sood K. Gagan, Sridevi Devaraj. Impact of Time-Restricted Feeding and Dawn-to-Sunset Fasting on Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease. Gastroenterology Research and Practice 2017; 2017 doi: 10.1155/2017/3932491
|
| 310 |
Snigdha Jyoti Das, Barsha Pathak, Sangit Dutta, Sujoy Bose, Purabi Deka Bose. Role of serum endotoxin, FGF19, TLR2, TNF-α, IL-12 and IL-10 in NAFLD-associated T2DM pathogenesis: Insights into Th1 bias and protective mechanisms. Indian Journal of Gastroenterology 2024; doi: 10.1007/s12664-024-01597-z
|
| 311 |
Saioa Gómez-Zorita, Maitane González-Arceo, Jenifer Trepiana, Leixuri Aguirre, Ana B Crujeiras, Esperanza Irles, Nerea Segues, Luis Bujanda, María Puy Portillo. Comparative Effects of Pterostilbene and Its Parent Compound Resveratrol on Oxidative Stress and Inflammation in Steatohepatitis Induced by High-Fat High-Fructose Feeding. Antioxidants 2020; 9(11) doi: 10.3390/antiox9111042
|
| 312 |
Waleska Dornas, Vincent Lagente. Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis. Pharmacological Research 2019; 141 doi: 10.1016/j.phrs.2019.01.026
|
| 313 |
Valerio Nobili, Antonella Mosca, Tommaso Alterio, Sabrina Cardile, Lorenza Putignani. Probiotics and Child Gastrointestinal Health. Advances in Experimental Medicine and Biology 2018; 1125 doi: 10.1007/5584_2018_318
|
| 314 |
Francesca Ubaldi, Claudia Frangella, Veronica Volpini, Paola Fortugno, Federica Valeriani, Vincenzo Romano Spica. Systematic Review and Meta-Analysis of Dietary Interventions and Microbiome in Phenylketonuria. International Journal of Molecular Sciences 2023; 24(24) doi: 10.3390/ijms242417428
|
| 315 |
Qiang Zheng, Hang Zhao, Dong Jia, Xu Han, Zhenning Liu, Min Zhao, Fumio Tsuji. Overexpression of TOLLIP Protects against Acute Kidney Injury after Paraquat Intoxication through Inhibiting NLRP3 Inflammasome Activation Modulated by Toll‐Like Receptor 2/4 Signaling. Mediators of Inflammation 2021; 2021(1) doi: 10.1155/2021/5571272
|
| 316 |
Filomena Del Piano, Baptiste Mateu, Lorena Coretti, Luca Borrelli, Giovanni Piccolo, Nicola Francesco Addeo, Sergio Esposito, Raffaelina Mercogliano, Luigia Turco, Rosaria Meli, Francesca Lembo, Maria Carmela Ferrante. Polystyrene microplastic exposure modulates gut microbiota and gut-liver axis in gilthead seabream (Sparus aurata). Science of The Total Environment 2024; 957 doi: 10.1016/j.scitotenv.2024.177857
|
| 317 |
Firas Alhasson, Suvarthi Das, Ratanesh Seth, Diptadip Dattaroy, Varun Chandrashekaran, Caitlin N. Ryan, Luisa S. Chan, Traci Testerman, James Burch, Lorne J. Hofseth, Ronnie Horner, Mitzi Nagarkatti, Prakash Nagarkatti, Stephen M. Lasley, Saurabh Chatterjee, Partha Mukhopadhyay. Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation. PLOS ONE 2017; 12(3) doi: 10.1371/journal.pone.0172914
|
| 318 |
Yizhe Cui, Qiuju Wang, Renxu Chang, Xiaocui Zhou, Chuang Xu. Intestinal Barrier Function–Non-alcoholic Fatty Liver Disease
Interactions and Possible Role of Gut Microbiota. Journal of
Agricultural and Food Chemistry 2019; 67(10) doi: 10.1021/acs.jafc.9b00080
|
| 319 |
Wenwen Zhao, Meng Xiao, Jie Yang, Li Zhang, Yinying Ba, Rongrong Xu, Zongyang Liu, Haiyan Zou, Ping Yu, Xia Wu, Xiaoqing Chen. The combination of Ilexhainanoside D and ilexsaponin A1 reduces liver inflammation and improves intestinal barrier function in mice with high-fat diet-induced non-alcoholic fatty liver disease. Phytomedicine 2019; 63 doi: 10.1016/j.phymed.2019.153039
|
| 320 |
Li‑Ping Han, Bei Sun, Chun‑Jun Li, Yun Xie, Li‑Ming Chen. Effect of celastrol on toll‑like receptor 4‑mediated inflammatory response in free fatty acid‑induced HepG2 cells. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3775
|
| 321 |
Xuran Wang, Bin Zhang, Runqiu Jiang. Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1467197
|
| 322 |
Sarit Anavi-Cohen, Gil Zandani, Nina Tsybina-Shimshilashvili, Ran Hovav, Noa Sela, Abraham Nyska, Zecharia Madar. Metabolic and Microbiome Alterations Following the Enrichment of a High-Fat Diet With High Oleic Acid Peanuts Versus the Traditional Peanuts Cultivar in Mice. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.823756
|
| 323 |
Sandra Martín-Peláez, Montse Fito, Olga Castaner. Mediterranean Diet Effects on Type 2 Diabetes Prevention, Disease Progression, and Related Mechanisms. A Review. Nutrients 2020; 12(8) doi: 10.3390/nu12082236
|
| 324 |
Jian Zheng, Congjun Li, Shuwen Li, Xiaodong Zheng. Decabromodiphenyl ethane (DBDPE) inhibited the growth and feeding by disrupting the gut and digestive gland homeostasis in octopus Amphioctopus fangsiao (Mollusca: Cephalopoda). Science of The Total Environment 2024; 956 doi: 10.1016/j.scitotenv.2024.177364
|
| 325 |
Dipro Bose, Punnag Saha, Ayan Mondal, Brian Fanelli, Ratanesh K. Seth, Patricia Janulewicz, Kimberly Sullivan, Stephen Lasley, Ronnie Horner, Rita R. Colwell, Ashok K Shetty, Nancy Klimas, Saurabh Chatterjee. Obesity Worsens Gulf War Illness Symptom Persistence Pathology by Linking Altered Gut Microbiome Species to Long-Term Gastrointestinal, Hepatic, and Neuronal Inflammation in a Mouse Model. Nutrients 2020; 12(9) doi: 10.3390/nu12092764
|
| 326 |
Stanislav Kotlyarov. Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease. World Journal of Gastroenterology 2023; 29(4): 597-615 doi: 10.3748/wjg.v29.i4.597
|
| 327 |
Cassandra Francella, Jane A. Foster. Burger's Medicinal Chemistry and Drug Discovery. 2021; doi: 10.1002/0471266949.bmc297
|